Visualizing the Cycle: Data Techniques for Menstrual Research and Clinical Translation

Abstract

This article provides a comprehensive guide to data visualization techniques tailored for menstrual cycle research, addressing the critical need for standardization in the field. Aimed at researchers, scientists, and drug development professionals, it bridges foundational concepts, methodological applications, and advanced computational approaches. We explore how effective visualization can uncover associations between hormonal fluctuations, physiological signals, and symptom patterns, while also tackling common methodological pitfalls. The content further examines the validation of emerging techniques like machine learning against established benchmarks and discusses the ethical implications of algorithm-driven insights, offering a holistic framework for robust, reproducible, and impactful cycle science.

Laying the Groundwork: Core Concepts and Standardization in Menstrual Cycle Data

The Critical Need for Standardization in Cycle Research

The study of the menstrual cycle as an independent variable is fraught with methodological inconsistencies that have substantially confused the scientific literature and limited opportunities for systematic reviews and meta-analyses [1]. Despite decades of investigation into the physiological and psychological effects of the menstrual cycle, research has insufficiently adopted consistent methods for operationalizing this fundamental biological process [1]. This lack of standardization is particularly problematic in the context of data visualization, where inconsistent phase definitions and sampling strategies create visual representations that cannot be meaningfully compared across studies. The problem extends beyond academic inconvenience—it represents a critical barrier to advancing women's health and understanding hormone-mediated phenomena in drug development.

The consequences of this standardization gap are far-reaching. When laboratories employ different methods for defining cycle phases, sampling data, and visualizing results, the scientific community loses the ability to synthesize knowledge effectively [1]. For example, a recent meta-analysis on cardiac vagal activity across the natural menstrual cycle managed to resolve previous inconsistencies only by applying a common definition of cycle phases post hoc to the 37 included studies [1]. This retrospective harmonization represents an inefficient approach to scientific progress. The situation is particularly dire for researchers studying premenstrual disorders, where the absence of standardized protocols has hampered the identification of hormone-sensitive individuals and the development of targeted interventions [1].

Current Challenges and Consequences

Methodological Inconsistencies

The fundamental challenge in menstrual cycle research stems from treating a within-person process as a between-subject variable. The menstrual cycle is inherently a within-person process characterized by predictable fluctuations of ovarian hormones estradiol (E2) and progesterone (P4) [1]. Despite this, many studies continue to employ between-subject designs that conflate within-subject variance (attributable to changing hormone levels) with between-subject variance (attributable to each individual's baseline symptom levels) [1]. This methodological flaw fundamentally limits the validity of findings and the utility of resulting visualizations.

Table 1: Common Methodological Pitfalls in Menstrual Cycle Research

Pitfall	Consequence	Impact on Visualization
Between-subject designs	Conflates within and between-subject variance	Obscures true cycle patterns
Inconsistent phase definitions	Precludes cross-study comparisons	Creates incompatible visual comparisons
Retrospective symptom reporting	Introduces recall bias	Generates misleading patterns in data visualizations
Variable sampling strategies	Captures different cycle aspects	Produces incomplete or non-comparable temporal patterns
Non-standardized hormone assessment	Creates incompatible datasets	Prevents meaningful meta-analyses of visualized data

The problem of retrospective symptom reporting deserves particular attention in the context of data visualization. Studies comparing retrospective and prospective premenstrual symptoms have found a remarkable bias toward false positive reports in retrospective self-report measures [1]. These retrospective reports do not converge better than chance with prospective daily ratings, and beliefs about premenstrual syndrome may influence retrospective measures [1]. When visualized, these inaccurate data create compelling but misleading patterns that can perpetuate false assumptions about cycle effects.

Impact on Data Visualization and Interpretation

The lack of standardization directly compromises the effectiveness of data visualization as an analytical tool. Without consistent phase definitions, visual representations of cycle effects become study-specific artifacts rather than generalizable knowledge. This problem is particularly acute for advanced visualization techniques such as cycle plots, which are specifically designed to identify seasonal trends and recurring patterns over time [2]. When applied to menstrual cycle data without standardized protocols, these powerful visualization tools produce outputs that cannot be aggregated or compared.

The consequences extend beyond academic research to clinical and drug development applications. In pharmaceutical research, inconsistent cycle monitoring can introduce uncontrolled variability that obscures treatment effects or generates misleading conclusions about drug safety and efficacy. For conditions known to be influenced by menstrual cycle phases, such as migraine, epilepsy, and various mood disorders, this lack of standardization can delay the development of effective therapies and personalized treatment approaches.

Standardized Protocols for Cycle Research

Core Definitions and Phase Specifications

Establishing a standardized vocabulary is the foundational step toward comparable cycle research and effective data visualization. The menstrual cycle is a natural process in the female reproductive system that repeats monthly from menarche to menopause, with an average length of 28 days (healthy range: 21-37 days) [1]. The cycle begins with the first day of menses and ends the day before the subsequent bleeding onset [1].

Table 2: Standardized Menstrual Cycle Phase Definitions

Phase	Start Point	End Point	Key Hormonal Characteristics
Follicular Phase	Onset of menses	Day of ovulation	Low and stable P4; rising E2 with pre-ovulatory spike
Luteal Phase	Day after ovulation	Day before next menses	Rising P4 and E2; mid-luteal P4 peak; secondary E2 peak
Periovulatory Phase	2 days before ovulation	Day of ovulation	Dramatic E2 spike; LH surge; low P4
Perimenstrual Phase	2 days before menses	2 days after menses onset	Rapid E2 and P4 withdrawal

The follicular phase derives its name from the maturation of ovarian follicles containing oocytes and begins with menses onset [1]. During this phase, progesterone levels remain consistently low while estradiol rises gradually through the mid-follicular phase before spiking dramatically just before ovulation [1]. The luteal phase is defined as the day after ovulation through the day before menses and is characterized by transformation of the dominant follicle into the corpus luteum, which produces both progesterone and estradiol [1]. The luteal phase has a more consistent length (average 13.3 days, SD=2.1) than the follicular phase (average 15.7 days, SD=3.0) [1].

Experimental Design and Data Collection

The gold standard approach to cycle research employs repeated measures designs that capture the within-person nature of menstrual cycle effects [1]. Daily or multi-daily (ecological momentary assessment) ratings represent the preferred method of data collection, as they provide the temporal density needed to accurately characterize cycle dynamics and create meaningful visualizations [1].

For resource-intensive data collection (e.g., psychophysiological measures, cognitive tasks), researchers must thoughtfully select the number and timing of assessments based on specific hypotheses [1]. Studies investigating estradiol effects might sample during the mid-follicular phase (low, stable estradiol and progesterone) and periovulatory phase (peak estradiol, low progesterone) [1]. Research examining progesterone interactions might add mid-luteal phase assessments (elevated progesterone and estradiol) and perimenstrual phases (falling estradiol and progesterone) [1].

Multilevel modeling represents the most appropriate statistical approach for analyzing menstrual cycle data, requiring at least three observations per person to estimate random effects [1]. For reliable estimation of between-person differences in within-person changes across the cycle, three or more observations across two cycles provides greater confidence in the reliability of these differences [1].

Quantitative Hormone Monitoring Protocol

The establishment of a gold standard for quantitative menstrual cycle monitoring represents a significant advancement in standardization efforts. The Quantum Menstrual Health Monitoring Study protocol exemplifies this approach by measuring four key reproductive hormones in urine (follicle-stimulating hormone/FSH, estrone-3-glucuronide/E13G, luteinizing hormone/LH, and pregnanediol glucuronide/PDG) to characterize patterns that predict and confirm ovulation, referenced to serum hormones and the gold standard of ultrasound-confirmed ovulation day [3].

This protocol involves participants tracking menstrual cycles for three months using an at-home quantitative urine hormone monitor (Mira monitor) to predict ovulation, with ovulation day confirmed through serial ultrasounds [3]. The study compares regular cycles (24-38 days) against two irregular cycle groups: individuals with polycystic ovarian syndrome (PCOS) and athletes with high exercise levels [3]. The hypothesis is that the quantitative urine hormone pattern will accurately correlate with serum hormonal levels and predict (via LH) and confirm (via PDG) the ultrasound day of ovulation in both regular and irregular cycles [3].

Table 3: Research Reagent Solutions for Quantitative Cycle Monitoring

Research Tool	Function	Application Context
Mira Fertility Monitor	Quantitative measurement of FSH, E13G, LH, PDG in urine	At-home hormone pattern tracking for ovulation prediction and confirmation
Carolina Premenstrual Assessment Scoring System (C-PASS)	Standardized diagnosis of PMDD and PME based on daily symptom ratings	Identification of hormone-sensitive individuals in research samples
Mansfield-Voda-Jorgensen Menstrual Bleeding Scale	Validated assessment of menstrual bleeding against physical fluid loss	Standardized quantification of bleeding patterns as menstrual health barometer
Quantitative Urine Hormone Strips	Lateral flow assays for LH, E1G, PDG	Point-of-care ovulation prediction and cycle phase confirmation
Anti-Müllerian Hormone (AMH) Serum Test	Ovarian reserve assessment	Contextualization of cycle characteristics within ovarian aging framework

The critical innovation in this protocol is the correlation of quantitative at-home hormone measurements with gold standard references (ultrasound and serum hormones), which may establish a new standard for remote clinical monitoring without labor-intensive follicular-tracking ultrasound or repeated serum sampling [3]. This approach addresses the complex dynamics of inter-related menstrual cycle hormones, for which single serum values are less valuable than daily variation patterns amenable to pattern recognition through visualized data [3].

Data Visualization Framework for Cycle Research

Standardized Visualization Approaches

Data visualization serves as a critical bridge between complex menstrual cycle data and meaningful interpretation, deepening understanding for those working directly with data while making patterns accessible to those less familiar with the underlying complexity [4]. In menstrual cycle research, effective visualization techniques must accommodate the multidimensional nature of cycle data, including hormonal patterns, symptom reports, and physiological parameters across time.

Cycle plots offer a particularly valuable visualization technique for menstrual cycle data, as they specialize in displaying seasonal trends over time and help identify patterns across multiple cycles [2]. These visualizations typically feature multiple line graphs, each representing a different cycle (e.g., individual months) plotted over time, allowing for easy comparison of cyclical trends and identification of recurring patterns [2]. When applied to menstrual cycle data, cycle plots can reveal consistent phase-locked symptom patterns or hormone profiles across multiple cycles.

For comparative visualization of quantitative data across cycle phases, histogram-based representations provide appropriate visualization of frequency distributions [5]. Unlike bar charts for categorical data, histograms treat the horizontal axis as a number line, making them suitable for numerical data such as hormone concentrations or symptom severity scores [5]. Frequency polygons offer an alternative representation that is particularly useful for comparing distributions of multiple sets of quantitative data on the same diagram [6].

Accessibility and Ethical Visualization

Accessibility considerations must be integrated into menstrual cycle data visualization to ensure content is perceivable by all users, including those with visual disabilities. Web Content Accessibility Guidelines (WCAG) specify contrast ratio requirements that should inform color choices in scientific visualizations [7]. The visual presentation of text and images of text should have a contrast ratio of at least 4.5:1, with large text (18pt+ or 14pt+bold) requiring at least 3:1 contrast [7]. Non-text elements such as graphical objects and user interface components must have a contrast ratio of at least 3:1 against adjacent colors [8].

Ethical visualization practices require honest scales, transparent reporting, and avoidance of misleading representations [9]. Visualizations should avoid truncated axes that exaggerate changes, misleading color scales that imply intensity where none exists, or selective reporting that hides poor performance [9]. The principle of clarity and simplicity dictates that each visualization should focus on one clear message, avoiding overloaded charts with too many layers that obscure the primary finding [9].

Implementation Guidelines and Future Directions

Integrated Research Protocol

Implementing standardized menstrual cycle research requires systematic attention to design, data collection, analysis, and visualization. The following integrated protocol provides a framework for generating comparable, visually representable data:

• Study Design: Employ repeated measures designs with at least three observations per cycle across two cycles to reliably estimate between-person differences in within-person changes [1]. Clearly state hypotheses and specify required sampling structure across targeted cycle phases and associated hormone levels before data collection.

• Participant Screening: Use prospective daily monitoring (e.g., C-PASS system) for at least two consecutive menstrual cycles to identify hormone-sensitive individuals and exclude those with premenstrual disorders unless specifically studying these populations [1]. For PCOS populations, apply Rotterdam criteria including historical cycle length variability [3].

• Cycle Phase Specification: Collect first day of menses data for cycle day calculation, confirm ovulation through LH surge testing or quantitative hormone monitoring, and assign phases using standardized definitions referenced to ovulation [1]. For irregular cycles, extend monitoring periods to capture representative patterns.

• Data Collection: Implement daily or multi-daily assessments for self-report measures, with strategic timing of resource-intensive measures (e.g., physiological assessments, cognitive tasks) aligned with key phase transitions [1]. Incorporate quantitative hormone monitoring where feasible to correlate subjective measures with objective hormonal changes.

• Visualization Standards: Apply consistent color coding across phases in all visualizations, implement accessibility standards for color contrast, and select visualization types based on research question (cycle plots for temporal patterns, histograms for distributions, scatter plots for relationships) [2] [5] [6].

The adoption of these standardized protocols will require coordinated effort across the research community, including development of shared computational tools, template visualization code, and standardized reporting guidelines for publications.

Future Directions in Standardized Cycle Research

The future of standardized cycle research points toward increased interactivity and automation in data visualization [4]. Interactive dashboards that allow users to explore data, visualize trends, and identify patterns will enhance accessibility for diverse stakeholders including patients, clinicians, and researchers [4]. These tools will enable stakeholders to make more informed decisions about environmental impacts and sustainability in pharmaceutical development and personal health [4].

Artificial intelligence and automation trends promise enhanced efficiency, accuracy, and consistency in data collection and analysis [4]. Automated pattern recognition in hormonal data may identify subtle cycle characteristics not apparent through manual analysis. These advancements will create more time for creative and thoughtful consideration when sharing visualizations and insights [4].

Staying at the forefront of this field requires continuous learning and adaptation to new technologies and methodologies, including monitoring latest developments in data visualization and automation, attending specialized workshops, and collaborating across disciplines [4]. Through such coordinated efforts, the research community can transform menstrual cycle research from a methodologically confused field to a paradigm of standardized, visually accessible scientific inquiry.

The menstrual cycle is a fundamental biological process characterized by predictable fluctuations in hormones and physiological parameters. For researchers and drug development professionals, a precise understanding of these changes is critical for designing robust studies, interpreting data related to women's health, and developing therapies that account for cyclic physiological variations. This document provides application notes and protocols, framed within a broader thesis on data visualization in menstrual cycle research, to standardize the investigation and representation of cycle phases. Accurate phase identification is paramount, as the menstrual cycle is fundamentally a within-person process, and its treatment as a between-subject variable lacks validity [1].

Defining the Menstrual Cycle Phases

The menstrual cycle is typically divided into several phases, each marked by distinct hormonal and physiological events. The average cycle length is 28 days, although healthy cycles can vary from 21 to 37 days [1]. The variability in total cycle length is primarily derived from the follicular phase, which can range from 10 to 16 days, whereas the luteal phase is more consistent, with an average length of 13.3 days (SD = 2.1) [1] [10].

Table 1: Definitive Characteristics of Menstrual Cycle Phases

Phase	Timing (Approx.)	Key Hormonal Features	Dominant Physiological/Ovarian Event
Menses	Days 1-5	Low and stable estradiol (E2) and progesterone (P4) [1] [11]	Sloughing of the uterine lining [10].
Follicular	End of menses until ovulation	Gradual rise in E2; P4 levels remain low [1] [12]	Recruitment, selection, and dominance of an ovarian follicle [10].
Ovulation	~Day 14	E2 spikes dramatically; Luteinizing Hormone (LH) surges [1] [10]	Release of a mature oocyte from the dominant follicle [10].
Luteal	Day after ovulation until next menses	Rising P4 and a secondary peak in E2, followed by a rapid perimenstrual withdrawal if no pregnancy occurs [1] [12]	Transformation of the ruptured follicle into the corpus luteum [10].

Hormonal Profiles and Quantitative Data

The orchestration of the cycle is governed by the hypothalamic-pituitary-ovarian axis. The following diagram illustrates the key signaling pathways and feedback loops that define each phase.

Figure 1: Hormonal Regulation of the Menstrual Cycle. This diagram summarizes the core signaling in the HPO axis. GnRH from the hypothalamus stimulates the pituitary to release FSH and LH, which act on the ovaries to produce E2 and P4. These gonadal hormones, in turn, provide feedback to the pituitary. The shift from negative to positive E2 feedback triggers the LH surge that induces ovulation.

Hormone levels are not static; their daily production rates change significantly across the cycle. The data in the table below, adapted from Baird and Fraser, provides quantitative values for these fluctuations, which are crucial for establishing in vitro models or assessing pharmacokinetics [10].

Table 2: Daily Production Rates of Key Sex Steroids Across the Cycle

Sex Steroids	Early Follicular	Preovulatory	Mid-Luteal
Progesterone (mg)	1	4	25
17α-Hydroxyprogesterone (mg)	0.5	4	4
Androstenedione (mg)	2.6	4.7	3.4
Testosterone (µg)	144	171	126
Estrone (µg)	50	350	250
Estradiol (E2) (µg)	36	380	250

Physiological Changes and Biomarkers for Tracking

Beyond hormones, several physiological parameters exhibit cyclic patterns, offering non-invasive biomarkers for phase identification. Recent research leverages these with machine learning for automated tracking [11] [13].

• Basal Body Temperature (BBT): Shows a characteristic biphasic pattern, with a sustained increase of approximately 0.3-0.5°C in the luteal phase due to rising progesterone [11].
• Heart Rate (HR) and Heart Rate Variability (HRV): Resting HR is generally higher in the luteal phase compared to the follicular phase [12] [13]. A novel feature, the heart rate at the circadian rhythm nadir (minHR), has been shown to improve luteal phase classification and ovulation prediction, outperforming BBT in individuals with variable sleep schedules [13].
• Neurostructural Dynamics: Emerging evidence from dense-sampling neuroimaging studies indicates that gonadal hormone fluctuations are associated with widespread, coordinated changes in brain volume and cortical thickness, underscoring the whole-body impact of the menstrual cycle [12].

Experimental Protocols for Phase Identification

Accurate phase identification is a prerequisite for meaningful research. The following protocols outline best practices, from gold-standard laboratory methods to emerging wearable-based techniques.

Gold-Standard Laboratory Confirmation

This protocol is essential for clinical trials or studies requiring high precision in phase identification [1] [10].

Title: Protocol for Laboratory-Based Menstrual Phase Identification

Objective: To definitively identify menstrual cycle phases using serum hormone assays and ovulation tests.

Materials:

• See "Research Reagent Solutions" table for essential materials.
• Equipment for venipuncture and serum separation.
• ELISA or mass spectrometry equipment for hormone assay.

Procedure:

• Participant Screening & Tracking: Recruit naturally cycling individuals. Have participants prospectively record the first day of their menstrual bleeding (Cycle Day 1) for at least two consecutive cycles.
• Schedule Visits: Plan laboratory visits based on the participant's cycle length.
  • Follicular Phase Visit: Schedule between CD 5-8.
  • Periovulatory Phase Visit: Schedule around expected ovulation (e.g., CD 12-14 in a 28-day cycle). Instruct participants to use at-home urinary LH test kits daily starting a few days before expected ovulation to detect the LH surge.
  • Luteal Phase Visit: Schedule 7-9 days after a detected LH surge or a positive urine test.
• Data Collection: At each visit, perform a venipuncture to collect blood samples for serum E2 and P4 analysis.
• Phase Confirmation:
  • Follicular Phase Confirmed: Low P4 and low-to-moderate E2.
  • Ovulation Confirmed: Serum LH > 20-40 mIU/mL or a positive urinary LH test. The day after the LH surge is considered the day of ovulation.
  • Luteal Phase Confirmed: Elevated P4 levels (> 15.9 nmol/l suggests an ovulatory cycle [12]).

Machine Learning-Based Identification Using Wearables

This protocol describes a modern, scalable approach for longitudinal monitoring in free-living conditions [11] [13].

Title: Protocol for Wearable-Based Phase Classification with Machine Learning

Objective: To classify menstrual cycle phases using physiological data from wrist-worn devices and a machine learning model.

Materials:

• A wrist-worn wearable device capable of continuous monitoring of skin temperature, heart rate (HR), and interbeat interval (IBI).
• Data processing infrastructure and machine learning software (e.g., Python, R).

Procedure:

• Data Collection: Participants wear the device continuously for the duration of the study (multiple cycles). The device records physiological signals like skin temperature, HR, IBI, and electrodermal activity.
• Ground Truth Labeling: Phases are labeled based on a reference method, such as the first day of menses (logged by the user) and a positive urinary LH test to pinpoint ovulation.
• Feature Engineering: Extract features from the raw physiological signals. Examples include:
  • Fixed Window: Features (e.g., mean nightly skin temperature) calculated over non-overlapping phases.
  • Rolling Window: Features calculated using a sliding window (e.g., 24-hour) to enable daily phase prediction.
  • Novel Features: Incorporate features like minHR (heart rate at the circadian rhythm nadir) [13].
• Model Training & Validation: Train a classifier (e.g., Random Forest, XGBoost) on the features to predict the phase labels. Use validation methods like leave-last-cycle-out or leave-one-subject-out to test generalizability. A Random Forest model using a fixed window for 3-phase classification has achieved 87% accuracy [11].

The workflow for this data-driven approach is summarized below.

Figure 2: Workflow for ML Phase Classification. This pipeline begins with continuous data collection from wearables, followed by the extraction of relevant physiological features. These features are used to train a machine learning model, which is then deployed to classify menstrual cycle phases.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials and Reagents for Menstrual Cycle Research

Item	Function/Application	Example Use Case
ELISA Kits for E2, P4, LH, FSH	Quantifying serum or saliva hormone levels to define cycle phases biochemically.	Gold-standard laboratory confirmation of follicular, ovulatory, and luteal phases [1] [10].
Urinary Luteinizing Hormone (LH) Test Kits	Detecting the LH surge that precedes ovulation by ~24-48 hours.	Pinpointing the transition from the follicular phase to ovulation in at-home or lab settings [1] [11].
Wrist-Worn Wearable Devices	Continuously monitoring physiological signals (skin temperature, HR, IBI) in free-living conditions.	Collecting high-density, longitudinal data for machine learning-based phase classification [11] [13].
Prospective Daily Symptom Logs	Tracking self-reported symptoms, bleeding, and basal body temperature.	Essential for identifying cyclical mood disorders (e.g., PMDD) and providing ground truth for phase labels [1].
Anti-Müllerian Hormone (AMH) Assay	Measuring ovarian reserve; believed to play a role in the selection of the dominant follicle [10].	Assessing a participant's baseline reproductive status in fertility-related studies.

This document provides a detailed framework for collecting, visualizing, and analyzing the essential data types in modern menstrual cycle associations research. It is structured to assist researchers, scientists, and drug development professionals in implementing robust protocols for investigating the complex interplay between hormonal fluctuations, physiological sensor data, and subjective symptom reporting. The integration of these multi-modal data streams is critical for advancing the field of women's health and developing targeted therapeutic interventions.

The note specifically outlines methodologies for capturing quantitative and qualitative data, presents experimental protocols for hormone monitoring and sensor data acquisition, and provides guidelines for effective data visualization tailored to cyclical data. Special emphasis is placed on the use of emerging technologies, including AI-driven analysis and wearable sensors, which are revolutionizing the granularity and continuity of data available for research [14] [15].

Essential Data Types for Menstrual Cycle Research

Comprehensive menstrual cycle research relies on the synchronous collection of data across multiple domains. The table below summarizes the core quantitative and categorical data types essential for a holistic analysis.

Table 1: Core Data Types in Menstrual Cycle Research

Data Category	Specific Data Types	Measurement Methods & Units	Visualization Recommendations
Hormonal Levels	Estrogen, Progesterone, LH, FSH, Cortisol	ng/mL, pg/mL (from blood, saliva, urine) [16]	Period-over-period line charts; correlated line plots with symptomology [17].
Physiological Sensor Data	Resting Heart Rate, Heart Rate Variability (HRV), Skin Temperature, Sleep Patterns	bpm, ms (milliseconds), °C, sleep stages (minutes) [14] [15]	Sequential color gradients on timeline charts; trend lines with cycle phase overlays [18].
Self-Reported Symptoms & Mood	Energy, Pain (cramping, headache), Mood (irritability, sadness), Digestion	Categorical scales (e.g., 1-5), Binary (Yes/No), Custom descriptive logs [19]	Categorical color palettes in daily tracker views; correlation matrices with hormone levels [20].
Cycle Phase & Event Logging	Menstrual Flow, Ovulation Confirmation, Sexual Activity	Binary indicators, Flow volume (categorical: light/medium/heavy)	Simple binary (present/absent) visualizations on a timeline; color-coded cycle phase charts [19].

Detailed Experimental Protocols

Protocol for Continuous Hormone Monitoring and Data Integration

Objective: To non-invasively track key reproductive hormones across the menstrual cycle and integrate this data with physiological sensor streams for a comprehensive biophysical profile.

Materials:

• Continuous hormone monitoring device (e.g., urine-based fertility monitor from Mira or OOVA, or saliva-based Hormometer from Eli Health) [16].
• Smartwatch or fitness tracker capable of monitoring heart rate, HRV, and skin temperature (e.g., Fitbit, Pixel Watch) [14].
• Data integration platform (e.g., custom database or research software like Bearable app for subjective symptom logging) [19].

Procedure:

• Participant Onboarding and Baseline Measurement: Obtain informed consent. Collect baseline demographic information and medical history. Guide the participant on the proper use of all devices.
• Daily Data Collection:
  • Hormone Tracking: Instruct the participant to perform a daily test at a consistent time (e.g., morning) using the hormone monitor. Record the quantitative values for hormones such as Estrogen and Luteinizing Hormone (LH) as provided by the device.
  • Sensor Data Acquisition: Ensure the participant wears the smartwatch continuously, especially during sleep, to capture 24/7 physiological data.
  • Symptom Logging: Prompt the participant to log any physical or emotional symptoms daily via the designated research app. Use consistent, predefined scales for metrics like energy, pain, and mood.
• Data Synchronization and Processing: Automate the daily transfer of data from the hormone monitor and smartwatch to the central research platform. Subjective logs are typically entered directly by the participant. Timestamps for all data points are crucial for alignment.
• Data Alignment and Analysis: Synchronize all data streams (hormone, sensor, symptom) on a unified timeline. Analyze for patterns and correlations, such as the relationship between the estrogen peak and a dip in resting heart rate, or the correlation between progesterone rise and self-reported fatigue.

The following workflow diagram illustrates the data collection and integration pipeline.

Protocol for AI-Driven Analysis of Sensor Data for Phase Prediction

Objective: To utilize artificial intelligence for predicting menstrual cycle phases (e.g., ovulation, menstruation onset) from wearable sensor data streams, potentially reducing reliance on frequent manual testing.

Materials:

• Pre-processed, time-series sensor data from wearables (e.g., R-R intervals for HRV, minute-level skin temperature).
• Computing environment with machine learning libraries (e.g., TensorFlow, PyTorch).
• Labeled dataset of confirmed cycle phases (e.g., from ovulation tests or hormonal confirmation).

Procedure:

• Data Preprocessing: Clean the raw sensor data to remove artifacts from non-physiological events (e.g., removing the watch). For temperature data, apply smoothing algorithms to reduce noise. Extract relevant features from HRV, such as the root mean square of successive differences (RMSSD) and standard deviation of NN intervals (SDNN).
• Model Training: Employ a deep neural network architecture, similar to models used for labor prediction [15]. The input layer consists of features like nightly minimum skin temperature, sleep-onset HRV, and resting heart rate. The output layer predicts a probability for a specific cycle phase (e.g., "pre-ovulatory," "ovulatory," "luteal").
• Model Validation and Interpretation: Train the model on a subset of the data and validate its performance on a held-out test set. Use accuracy, precision, and recall metrics. Leverage model interpretation tools (e.g., SHAP values) to understand which sensor features (e.g., a sustained temperature shift) are most contributory to the predictions.

The following diagram outlines the AI model training and prediction workflow.

The Scientist's Toolkit: Research Reagent Solutions

The following table details key materials and technologies used in advanced menstrual cycle research.

Table 2: Essential Research Materials and Technologies

Item / Technology	Function / Application	Example Use Case in Research
SensorLM Foundation Model [14]	AI model that interprets wearable sensor data and generates natural language descriptions.	Generating descriptive captions for sensor data segments (e.g., "period of elevated stress followed by physical activity") to simplify qualitative analysis.
Continuous Hormone Monitor (e.g., Mira, OOVA) [16]	Provides quantitative, at-home tracking of key reproductive hormones from urine.	Building precise, daily hormone profiles to correlate with physiological and subjective symptom data across the cycle.
Holistic Health Tracking App (e.g., Bearable) [19]	Allows for customizable logging of symptoms, mood, medication, and sleep in one platform.	Enabling participants to easily log a wide array of subjective metrics, which can be visually correlated with other data streams.
Polyamine Isolation Buffer [21]	A chemical buffer used in chromosome isolation protocols for genetic analysis.	Preparing high-quality chromosome samples for karyotyping in studies investigating genetic components of menstrual disorders like PCOS or endometriosis.
DAPI / Propidium Iodide Stain [21]	Fluorescent dyes that bind to DNA for chromosome identification and analysis via flow cytometry.	Staining chromosomes for flow karyotyping to detect potential structural abnormalities linked to reproductive health conditions.

Data Visualization Guidelines for Cyclical Data

Effective visualization is paramount for interpreting the complex, time-series data inherent in cycle research. Adherence to the following principles is recommended:

• Utilize Period-over-Period Charts: This is a primary tool for comparing cycles. For example, overlaying line charts of hormone levels or resting heart rate from multiple cycles can reveal consistent patterns and anomalies [17].
• Implement Strategic Color Coding:
  • Use a Single Hue for Continuous Data: Represent a single metric like estrogen levels using a sequential palette (e.g., light to dark pink) to intuitively show low-to-high values [18] [20].
  • Apply Contrasting Colors for Categorical Data: Use distinct hues (e.g., blue for follicular, red for luteal) to differentiate cycle phases or different data types (hormones vs. symptoms) [18].
  • Leverage Grey for Context: Use grey to display data from all cycles as background context, while highlighting the primary cycle of interest in a bold color. This provides immediate visual comparison [20].
• Ensure Accessibility: Choose color palettes with sufficient contrast and avoid red-green combinations to accommodate color vision deficiencies. Tools like Datawrapper's colorblind-check can verify this [20].
• Create Correlation Matrices: To visualize relationships between different data types (e.g., hormone X vs. symptom Y), use a diverging color palette in a correlation matrix. This quickly highlights strong positive (blues) and negative (reds) associations [18].

The following diagram summarizes the decision process for creating effective visualizations.

Foundational Visualization Techniques for Exploratory Analysis

Core Exploratory Data Analysis (EDA) Techniques

Exploratory Data Analysis (EDA) is a critical step in the data analysis process, using statistical and visualization tools to summarize data, uncover patterns, generate hypotheses, and test assumptions [22] [23]. The insights from EDA are pivotal for further analysis, statistical modeling, and machine learning applications [22]. The table below summarizes foundational visualization techniques for EDA, with particular consideration for menstrual cycle research data.

Table 1: Foundational Visualization Techniques for Exploratory Data Analysis

Visualization Type	Primary Use Case in EDA	Application in Menstrual Cycle Research	Key Interpretive Insights
Histogram [22]	Display distribution of a single continuous variable.	Visualize the distribution of hormone levels (e.g., estradiol) across all participants or within a cycle phase.	Reveals data skewness, central tendency, and spread, helping to assess normality.
Box Plot [22] [23]	Display distribution, central tendency, spread, and potential outliers of a dataset.	Compare symptom severity, cognitive task scores, or hormone concentrations across different menstrual cycle phases.	Identifies outliers, shows median and quartiles, and indicates symmetry of data.
Scatter Plot [22] [23]	Show the relationship between two continuous variables.	Explore the correlation between estradiol levels and performance on a behavioral task (e.g., reaction time).	Identifies patterns like trends (positive/negative correlation), clusters, or outliers.
Bar Chart [22]	Visualize and compare categorical variables.	Compare the mean accuracy on a Hand Laterality Judgment Task (HLJT) between the menstrual, follicular, and luteal phases.	Easily identifies the most prevalent categories and their relative proportions.
Line Chart [22]	Visualize trends over time or across ordered categories.	Plot daily ratings of a prospective symptom (e.g., irritability) across an entire menstrual cycle.	Highlights trends, patterns, or fluctuations in time-series or sequentially ordered data.
Violin Plot [22]	Display the distribution of a continuous variable.	Compare the distribution of progesterone levels in the luteal phase between participants with PMDD and controls.	Offers insights into the spread, central tendency, and shape (e.g., multimodality) of the distribution.

Experimental Protocols for Menstrual Cycle Research

Studying the menstrual cycle requires standardized methods for operationalizing the cycle as an independent variable to ensure meaningful and replicable results [1]. The following protocols detail key methodologies.

Protocol for Defining and Confirming Menstrual Cycle Phases

Objective: To accurately define and confirm phases of the menstrual cycle for subsequent analysis of behavioral or physiological outcomes.

Background: The menstrual cycle is a within-person process characterized by predictable fluctuations of ovarian hormones estradiol (E2) and progesterone (P4) [1]. The average cycle length is 28 days, varying healthily between 21 and 37 days [1]. The follicular phase begins with menses onset and lasts through ovulation, characterized by low P4 and a pre-ovulatory E2 spike. The luteal phase lasts from the day after ovulation until the day before the next menses, characterized by rising and then falling levels of P4 and E2 [1]. The luteal phase has a more consistent length (average 13.3 days) than the follicular phase (average 15.7 days) [1].

Materials:

• Prospective Menstrual Bleeding Calendar: For participants to record the first day of each menstrual bleed.
• Ovulation Test Kits: Urinary luteinizing hormone (LH) surge tests to pinpoint ovulation.
• Blood Collection Supplies: For assaying serum E2 and P4 levels to biochemically confirm cycle phases.

Methods:

• Participant Screening & Tracking: Enroll individuals with regular menstrual cycles (e.g., 22-35 days) [24]. Exclude those using hormonal contraception. Have participants prospectively track their menstrual bleeding dates for at least two cycles prior to data collection [1].
• Phase Definition:
  • Menstrual Phase: First few days of menstrual bleeding (days 1-5) when E2 and P4 are low.
  • Follicular Phase: From the end of the menstrual phase until ovulation. The mid-follicular phase can be targeted for low, stable E2 and P4.
  • Ovulation: Identified by a positive urinary LH test.
  • Luteal Phase: From the day after ovulation until the day before the next menses. The mid-luteal phase (approximately 7 days after ovulation) is targeted for high P4 [1].
• Biochemical Confirmation: In the mid-luteal phase, collect a blood sample to measure serum progesterone. A level >10 nmol/l is often used to confirm ovulation [24].
• Data Coding: Code cycle day based on the first day of menses as "day 1". Code cycle phases based on the above definitions for statistical modeling.

Protocol for a Hand Laterality Judgment Task (HLJT) with EEG

Objective: To investigate implicit motor imagery performance and its neurophysiological correlates across the menstrual cycle [24].

Background: The HLJT requires individuals to identify the laterality of a presented hand image, engaging implicit motor imagery. Performance and associated brain activity, such as Rotation-Related Negativity (RRN), can be modulated by menstrual cycle phase [24].

Materials:

• Stimulus Presentation Software: (e.g., PsychoPy, E-Prime) to display hand images.
• HLJT Stimuli: 3D images of right and left hands in different views (palm, back) and orientations (0° to 330° in 30° steps) [24].
• Response Input Device: A two-button mouse or keyboard for left/right responses.
• Electroencephalography (EEG) System: With a sufficient number of electrodes (e.g., 64-channel) to record event-related potentials (ERPs).
• Data Analysis Software: For behavioral analysis (e.g., R, Python) and EEG processing (e.g., EEGLAB, ERPLAB).

Methods:

• Participant Preparation: Recruit right-handed, naturally cycling females. Apply EEG cap according to standard protocol.
• Task Procedure:
  • In each trial, present a single hand image on a screen.
  • Instruct the participant to indicate as quickly and accurately as possible whether the image is a left or right hand using the designated buttons.
  • Record reaction time (RT) and accuracy for each trial.
• Experimental Design:
  • Utilize a within-subjects design where each participant completes the HLJT during multiple predefined menstrual cycle phases (e.g., menstrual, follicular, luteal) [1] [24].
  • A minimum of three observations per person across one cycle is considered a minimal standard for estimating within-person effects [1].
• Data Analysis:
  • Behavioral: Calculate mean accuracy and median RT for each participant in each cycle phase. Use multilevel modeling to test for within-person effects of the cycle phase on performance [1].
  • EEG: Segment EEG data around each stimulus presentation. Calculate ERPs and quantify components like P100 (stimulus characteristics) and RRN (implicit motor imagery) [24].

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials and Tools for Menstrual Cycle Visualization and Analysis

Item / Tool	Function / Purpose	Example Use Case
R Programming Language & Tidyverse [25] [23]	An open-source tool for statistical computing, data wrangling (dplyr), and data visualization (ggplot2).	Creating publication-quality box plots and line charts to visualize hormone levels and symptom scores across cycle phases.
Python (Pandas, Matplotlib, Seaborn) [23]	Handling large datasets (Pandas) and creating a wide variety of static, animated, and interactive visualizations.	Automating the processing of daily symptom diaries and generating multi-panel figures for exploratory analysis.
ColorBrewer & Viz Palette [26]	Online tools for selecting accessible, colorblind-safe qualitative, sequential, and diverging color palettes.	Choosing a qualitative palette for distinguishing three cycle phases on a plot, ensuring accessibility for all readers.
Urinary Luteinizing Hormone (LH) Test Kits [1]	Pinpointing the day of ovulation to objectively define the transition from the follicular to the luteal phase.	Scheduling mid-luteal phase laboratory visits for physiological data collection based on a detected LH surge.
Enzyme Immunoassay Kits	Quantifying serum levels of steroid hormones like estradiol (E2) and progesterone (P4) from blood samples.	Biochemically confirming participation in the intended menstrual cycle phase (e.g., high P4 in the luteal phase).
Prospective Daily Symptom Rating Scales [1]	Tracking daily symptoms to diagnose premenstrual disorders (e.g., with the C-PASS system) or control for symptom confounding.	Differentiating participants with PMDD from healthy controls in a study on cycle effects on cognition.

Data Visualization Best Practices and Color Application

Effective use of color is a major factor in creating clear and accessible data visualizations [26].

Color Palette Types:

• Qualitative Palettes: Used for categorical data without inherent ordering (e.g., menstrual cycle phases). Colors should be distinct, and the palette should be limited to ten or fewer colors [26].
• Sequential Palettes: Used for numeric data that has ordered values. Lighter colors typically represent lower values and darker colors higher values, often using a single hue or spanning between two hues [26].
• Diverging Palettes: Used when a meaningful central value exists (e.g., a neutral point or zero). They combine two sequential palettes, with a light color at the center and darker colors at both extremes [26].

Key Practices:

• Accessibility: About 8% of men and 0.4% of women have color vision deficiency. Avoid relying on hue alone; vary lightness and saturation. Use simulators like Coblis or Viz Palette to check visualizations [26].
• Contrast: Ensure sufficient contrast between text and its background. For non-text elements, explicitly set colors for arrows, symbols, and node text to ensure high contrast against their backgrounds.
• Restraint: Avoid unnecessary color. Use a neutral gray for non-critical elements and color only to highlight key findings or encode specific variables [26].
• Consistency: Use the same colors to represent the same groups or entities across all charts in a report or dashboard [26].

Identifying Key Research Questions and Associated Data Patterns

Menstrual cycle research is fundamental to understanding female physiology, reproductive health, and associated disorders. The complex, dynamic interplay of hormones necessitates precise data collection and robust visualization techniques to decode underlying patterns and relationships. This document outlines the key research questions, provides structured quantitative data summaries, details experimental protocols for key methodologies, and offers visualization schematics to standardize and enhance research practices in this field. The integration of advanced tracking technologies and machine learning with traditional biochemical assays is creating new paradigms for quantitative, personalized cycle monitoring.

Key Research Questions & Data Patterns

Research in menstrual cycle monitoring is driven by several core questions, each associated with distinct data patterns and appropriate visualization strategies.

Table 1: Key Research Questions and Associated Data Patterns

Research Question	Relevant Data Patterns	Primary Data Types	Suggested Visualization
1. How accurately can machine learning models classify menstrual cycle phases using physiological signals from wearables?	- Phase-specific shifts in skin temperature, heart rate, and heart rate variability [11] [13].- Distinct hormonal profiles (LH surge, PDG rise) corresponding to physiological changes [11].	Time-series physiological data (HR, IBI, EDA, temp) [11]; Phase labels (P, F, O, L) [11].	Line graphs for temporal trends; Confusion matrices for model performance [11].
2. How do urinary hormone metabolite levels correlate with the gold-standard ultrasound day of ovulation and serum hormone levels?	- Urinary LH surge precedes ovulation by ~24-48 hours [3].- Rise in urinary PDG confirms ovulation post-factum [3].- Follicular growth pattern on ultrasound culminating in collapse [3].	Quantitative urine hormones (LH, PDG, E1G, FSH) [3]; Serum hormone levels; Ultrasound follicular diameter [3].	Overlaid line charts (urine hormones vs. serum vs. follicle size); Scatter plots with correlation coefficients [3].
3. What are the primary user motivations and satisfaction levels with different menstrual cycle tracking technologies?	- High usage of urine hormone monitors and apps for avoiding pregnancy [27].- High reported satisfaction and contribution to health knowledge among users [27].	Survey data on motivation, technology used, satisfaction, perceived diagnostic aid [27].	Bar charts for motivation frequency; Stacked bar charts for satisfaction rates [27].
4. How does a circadian rhythm-based heart rate metric compare to traditional BBT for phase classification in individuals with variable sleep?	- minHR provides a more robust signal than BBT in sleep-disrupted cycles [13].- minHR-based models reduce ovulation prediction error in high sleep variability groups [13].	Daily minHR; Basal Body Temperature (BBT); Sleep timing data [13].	Paired line charts comparing minHR and BBT trajectories; Bar charts of prediction error across methods [13].

Quantitative Data Synthesis

Table 2: Performance Metrics of Machine Learning Models for Menstrual Phase Classification (Fixed Window Technique)

Model	Number of Phases Classified	Accuracy (%)	Precision (%)	Recall (%)	F1-Score (%)	AUC-ROC	Citation
Random Forest	3 (P, O, L)	87	87	87	87	0.96	[11]
Random Forest	4 (P, F, O, L)	71	Data not specified in source	Data not specified in source	Data not specified in source	0.89	[11]
Logistic Regression	4 (P, F, O, L)	63	Data not specified in source	Data not specified in source	Data not specified in source	Data not specified in source	[11]
XGBoost (minHR-based)	2 (Luteal vs. Non-Luteal)	Significantly outperformed BBT-based model	Data not specified in source	Significantly improved Luteal Recall	Data not specified in source	Data not specified in source	[13]

Table 3: User Motivations and Technology Adoption in Menstrual Cycle Tracking (n=368)

Category	Percentage (%)	Notes	Citation
Primary Motivation: To Avoid Pregnancy	72.8	Most frequently selected primary motivation.	[27]
Technology Used
- Urine Hormone Test/Monitor	81.3	Most frequently used technology.	[27]
- Smartphone App	68.8	Second most frequently used technology.	[27]
- Temperature Tracking Device	31.5		[27]
Reported Aid in Diagnosis		Among users with these conditions.
- Polycystic Ovary Syndrome (PCOS)	63.6		[27]
- Endometriosis	61.8		[27]
- Infertility	75.0		[27]
High Satisfaction with Technology	87.2	Reported a high degree of satisfaction.	[27]

Experimental Protocols

Protocol: Gold-Standard Validation of Urinary Hormone Monitors

This protocol outlines the methodology for establishing the correlation between at-home urine hormone monitors, serum hormone levels, and the ultrasound-confirmed day of ovulation [3].

I. Objective To characterize quantitative urine hormone patterns and validate them against serum hormonal measurements and the gold standard of ultrasound-defined ovulation in participants with regular and irregular menstrual cycles [3].

II. Materials

• Participants: Recruit three cohorts: 1) Regular cycles (24-38 days), 2) Irregular cycles due to PCOS, 3) Irregular cycles due to high-level exercise. Target ~50 participants per group over 3 cycles for 150 cycles total [3].
• At-Home Device: Quantitative urine hormone monitor (e.g., Mira monitor) and corresponding test strips measuring FSH, E1G, LH, and PDG [3].
• Clinical Tools:
  • Phlebotomy supplies for serum collection.
  • Ultrasonography machine with endovaginal probe for follicular tracking.
  • Validated menstrual bleeding scale (e.g., Mansfield–Voda–Jorgensen Scale) [3].
  • Customized app for tracking bleeding and temperature.

III. Procedure

• Screening & Consent: Eligible participants provide informed consent and complete baseline assessments.
• Daily At-Home Tracking:
  • Participants use the urine hormone monitor daily throughout the study cycle.
  • Participants log daily bleeding intensity and subjective symptoms via the app.
• Clinical Visits - Follicular Tracking & Serum Sampling:
  • Begin serial ultrasounds and serum draws when urine E1G levels begin to rise or when a leading follicle reaches ~14mm.
  • Continue daily visits until follicle rupture (ovulation) is confirmed via ultrasound. The day of ovulation is defined as the day the dominant follicle disappears or significantly decreases in size with subsequent sonographic signs [3].
• Post-Ovulation:
  • Continue daily urine monitoring for at least 7 days post-ovulation to track the PDG rise.
• Data Integration:
  • Align all data (urine hormones, serum hormones, ultrasound findings) by cycle day relative to the ultrasound-defined day of ovulation (Day 0).

IV. Data Analysis

• Correlation Analysis: Calculate correlation coefficients between urine and serum levels for each hormone (LH, PDG, E1G, FSH).
• Accuracy Metrics: Determine the accuracy of the urine LH peak in predicting the day of ovulation (within ±1 day). Assess the accuracy of PDG rise in confirming ovulation has occurred.
• Pattern Analysis: Compare hormone pattern profiles (amplitude, duration) between the regular and irregular cycle groups.

Protocol: Machine Learning Classification of Cycle Phases from Wearable Data

This protocol describes the process of training and validating machine learning models to identify menstrual cycle phases using physiological data from a wrist-worn device [11].

I. Objective To develop a classifier that automatically identifies menstrual cycle phases (e.g., Period, Follicular, Ovulation, Luteal) from continuous, passive physiological signals.

II. Materials

• Participants: Healthy, premenopausal women with ovulatory cycles.
• Device: A research-grade wristband (e.g., Empatica E4, EmbracePlus) capable of recording heart rate (HR), interbeat interval (IBI), electrodermal activity (EDA), and skin temperature [11].
• Ground Truth: Cycle phase labels determined by a reference method, such as at-home urine luteinizing hormone (LH) tests to pinpoint ovulation and cycle day tracking [11].

III. Procedure

• Data Collection:
  • Participants wear the wristband continuously for multiple cycles.
  • Participants perform daily urine LH testing to detect the LH surge.
  • The first day of menses is recorded for each cycle.
• Data Labeling (Ground Truth):
  • Menses (P): Days of menstrual bleeding.
  • Ovulation (O): Period spanning 2 days before to 3 days after a positive LH test [11].
  • Luteal (L): From the end of the ovulation phase until the next menses.
  • For 4-phase classification, the follicular (F) phase is from the end of menses until the start of ovulation.
• Feature Engineering:
  • Fixed Window: Extract features (e.g., mean, max, min, variance) from non-overlapping windows (e.g., 24-hour periods) for each signal [11].
  • Rolling Window: Extract features using a sliding window (e.g., 24-hour window sliding by 1 hour) for daily phase tracking [11].
• Model Training & Validation:
  • Models: Train multiple classifiers (e.g., Random Forest, XGBoost, Logistic Regression).
  • Validation: Use a leave-last-cycle-out approach (train on a participant's first n-1 cycles, test on the last cycle) or a more stringent leave-one-subject-out approach (train on all but one participant, test on the left-out participant) [11].

IV. Data Analysis

• Evaluate model performance using accuracy, precision, recall, F1-score, and Area Under the Receiver Operating Characteristic Curve (AUC-ROC) for each phase [11].
• Analyze which physiological features (e.g., night-time heart rate, skin temperature) are most important for classification.

Data Visualization Schematics

Diagram: Multi-Method Menstrual Cycle Phase Validation Workflow

Diagram: Menstrual Cycle Hormonal & Physiological Data Patterns

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Materials for Advanced Menstrual Cycle Research

Item / Solution	Function / Application	Specific Examples / Notes
Quantitative Urine Hormone Monitor	Precisely measures concentration of key reproductive hormones (FSH, LH, E1G, PDG) in urine at home for dynamic hormone pattern analysis [3].	Mira Fertility Tracker; Clearblue Fertility Monitor. Provides numerical values, not just binary results [27] [3].
Research-Grade Wearable Device	Passively and continuously collects high-fidelity physiological data for machine learning model training and phase classification [11].	Empatica E4; EmbracePlus; Oura Ring. Should capture HR, HRV, skin temperature, and EDA [11].
At-Home Luteinizing Hormone (LH) Test Strips	Provides a ground-truth marker for the LH surge, which is critical for accurately labeling the ovulation phase in training datasets [11] [28].	Commonly available qualitative urine test strips. Used to define the "Ovulation" phase window (e.g., -2 to +3 days from positive test) [11].
Ultrasound with Endovaginal Probe	The gold-standard method for confirming follicular development, rupture (ovulation), and endometrial changes [3].	Used in serial scans during the late follicular phase to pinpoint the estimated day of ovulation (EDO) with high precision [3].
Validated Symptom & Bleeding Log	Captures subjective patient-reported outcomes and objective bleeding patterns, contextualizing biochemical and physiological data [3].	Digital apps are preferred. Should use validated scales like the Mansfield–Voda–Jorgensen Menstrual Bleeding Scale [3].
Machine Learning Classifiers	Algorithms that identify complex, non-linear patterns in multi-parameter data to predict cycle phases and fertile windows [11] [13].	Random Forest, XGBoost. Effective for time-series physiological data and achieving state-of-the-art accuracy [11] [13].

From Data to Discovery: Applied Visualization Techniques for Cycle Analysis

Application Note: Data Standardization and Presentation for Longitudinal Cycle Studies

Within menstrual cycle associations research, the accurate visualization of temporal data is paramount for distinguishing meaningful physiological patterns from random fluctuation. This document establishes standardized protocols for presenting quantitative hormonal and symptom data, framing them within the context of a broader thesis on data visualization techniques in longitudinal biomedical research. The recommended practices address the persistent methodological challenge noted in meta-analyses, where "inconsistent definition of cycle phases" and "inconsistent methods of operationalizing the menstrual cycle" have led to significant confusion in the literature and frustrate attempts at systematic reviews and meta-analysis [28] [29]. These guidelines are designed to enhance reproducibility, facilitate cross-study comparisons, and ensure visualizations communicate scientific findings with clarity and precision for research, scientific, and drug development audiences.

Structured Data Presentation

Effective analysis begins with organized data collection. The following tables provide standardized frameworks for capturing core data points in menstrual cycle research.

Table 1: Core Daily Menstrual Cycle Tracking Variables

Variable Name	Variable Type	Unit of Measurement	Data Format	Description
Participant ID	Categorical (Nominal)	Text	Alphanumeric	Unique study identifier for each participant
Cycle Day	Numerical (Discrete)	Days	Integer	Day 1: First day of menstrual bleeding [28]
Phase	Categorical (Ordinal)	Text	Menstrual, Follicular, Ovulatory, Luteal	Cycle phase determined via forward/backward count or hormonal assay [28]
Estradiol (E2)	Numerical (Continuous)	pg/mL	Floating Point	Serum or salivary concentration
Progesterone (P4)	Numerical (Continuous)	ng/mL	Floating Point	Serum or salivary concentration
Symptom Severity	Numerical (Discrete)	Scale (e.g., 0-10)	Integer	Self-reported intensity of specific symptoms
Basal Body Temp (BBT)	Numerical (Continuous)	°C	Floating Point	Morning resting temperature

Table 2: Recommended Table Structure for Presenting Frequency Data of Cycle Characteristics

Characteristic	Absolute Frequency (n)	Relative Frequency (%)	Cumulative Frequency (%)
Total Participants	2,414	100.0	-
Cycle Length (days)
21-25	450	18.6	18.6
26-30	1,355	56.1	74.7
31-35	559	23.2	97.9
36+	50	2.1	100.0
Premenstrual Symptoms
Present	559	23.2	23.2
Absent	1,855	76.8	100.0

Table 2 exemplifies a self-explanatory frequency distribution table. The title, headings, and data are organized for quick understanding without detailed reference to the text. Percentages sum to 100%, and the total number of observations is clearly stated [30] [6].

Experimental Protocols

Protocol A: Determining Menstrual Cycle Phase for Study Visits

This protocol details a robust methodology for scheduling laboratory visits during specific menstrual cycle phases, a critical step for ensuring valid within-person comparisons [28].

Background and Principle

The menstrual cycle is fundamentally a within-person process, and study designs must account for between-person differences in baseline symptom levels and cycle sensitivity [28] [29]. Accurate phase determination is essential for reducing noise and bias in temporal visualizations of hormonal and symptom data.

Materials and Equipment

• Menstrual cycle tracking diary (digital or paper)
• Calendar or digital date calculator
• Urinary Luteinizing Hormone (LH) test kits
• Basal Body Thermometer (BBT)
• Data collection form (see Table 1)

Step-by-Step Procedure

• Initial Cycle Day Calculation: Participants report the first day of their last menstrual period (LMP). The first day of menstrual bleeding is designated as Cycle Day 1 [28].
• Forward-Count Method for Follicular Phase: For visits targeting the early cycle (e.g., menstrual phase), count forward from the LMP. Schedule visits occurring within the timeline from Day 1 to approximately Day 10 [28].
• Backward-Count Method for Luteal Phase: For visits targeting the late cycle (e.g., mid-luteal phase), first estimate the next menstrual period start date. Then count backward 7 days to target the mid-luteal phase [28].
• Ovulation Confirmation (Optional but Recommended): To increase precision, provide participants with urinary LH test kits to detect the LH surge, which precedes ovulation by 24-36 hours. A visit scheduled 7 days post-LH surge reliably targets the mid-luteal phase [28].
• Phase Verification: Where resources allow, collect a serum progesterone sample during the luteal phase visit. A progesterone level >5 ng/mL provides objective confirmation of ovulation [28].

Protocol B: Creating a Period-Over-Period Symptom Tracker

This protocol outlines the creation of a period-over-period chart to visualize and compare symptom trends across multiple cycles, helping to identify recurring patterns and treatment effects.

Background and Principle

A period-over-period chart compares data from similar periods, such as consecutive menstrual cycles, to emphasize changes and trends while controlling for cyclical variation [17]. This is crucial for tracking the efficacy of interventions in clinical trials or for understanding the natural history of menstrual-related disorders.

Materials and Equipment

• Longitudinal dataset with structured daily data (per Table 1)
• Data visualization software (e.g., R, Python, Excel, Domo)
• Color palette adhering to specified contrast guidelines

Step-by-Step Procedure

• Data Aggregation: For each participant and each cycle, calculate the average daily symptom severity for each cycle phase (Menstrual, Follicular, etc.).
• Data Structuring: Organize the data with cycles as the primary period (e.g., Cycle 1, Cycle 2, Cycle 3) on the x-axis and the aggregated symptom score on the y-axis.
• Chart Selection: Use a grouped bar chart or a multi-line chart. A grouped bar chart effectively compares the same phase across different cycles, while a line chart can show the trajectory of a phase's severity over time [17].
• Visual Refinement:
  • Ensure the baseline value for the y-axis is set appropriately to accurately represent comparisons; for bar charts, starting at zero is recommended [17].
  • Use a consistent and comparable measurement interval (e.g., compare full cycles to full cycles, not a cycle to a single week) [17].
  • Apply a muted, contrasting color palette to differentiate data series (e.g., different cycles). Use stronger colors to highlight significant variances or key data points. Limit comparisons to four or five trendlines to avoid visual clutter [17].

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for Hormonal and Symptom Tracking Research

Item	Function & Application in Research	Specification Notes
Urinary LH Test Kits	Predicts ovulation for precise timing of luteal-phase study visits. Confirms ovulatory cycles.	Qualitative, rapid immunoassays. Use according to manufacturer's protocol starting ~Day 10.
Basal Body Thermometer	Tracks the biphasic shift in resting body temperature to confirm ovulation retrospectively.	High-precision (0.05°C resolution). Must be used immediately upon waking, before any activity.
Salivary Hormone Assay Kits	Non-invasive measurement of bioavailable estradiol and progesterone for frequent sampling.	ELISA-based. Correlates with serum levels for estradiol [28]. Requires strict adherence to timing and collection guidelines.
Validated Symptom Scales	Quantifies subjective experiences (e.g., mood, pain, bloating) for statistical analysis and visualization.	Use published scales (e.g., for PMDD). Prefer daily prospective ratings over retrospective recall to reduce bias [29].
Electronic Data Capture (EDC) System	Securely collects daily participant-reported data on symptoms, timing, and medication use.	Should be HIPAA/GCP-compliant, user-friendly, and allow for real-time data monitoring by researchers.

Visualization Workflows and Data Analysis Logic

Research Workflow for Temporal Data

Data Analysis Pipeline

Application Note: Core Concepts and Methodological Rationale

The Critical Importance of Within-Subject Designs in Menstrual Cycle Research

The menstrual cycle represents a fundamental within-person process characterized by dynamic hormone fluctuations that create natural experimental conditions for studying neuroendocrine-behavioral relationships. Treating cycle phase as a between-subject variable conflates within-subject variance (attributable to changing hormone levels) with between-subject variance (attributable to each individual's baseline characteristics), thereby compromising validity [1]. The gold standard approach involves repeated measures designs where participants serve as their own controls across multiple cycle phases [1]. This methodology effectively controls for stable between-person confounds and increases statistical power to detect hormone-behavior relationships.

Research demonstrates that within-subject designs require fewer participants to detect effects and minimize random noise in data by ensuring that participant-specific characteristics (e.g., baseline cognitive ability, personality traits, environmental factors) equally affect all conditions [31]. For example, a participant's unique history, background knowledge, and momentary state (e.g., fatigue, mood) will consistently influence their performance across all cycle phases, whereas these factors introduce uncontrolled variability in between-subject designs [31].

The Challenge of Phase Determination in Menstrual Cycle Studies

Accurately determining menstrual cycle phase presents significant methodological challenges. Commonly used projection methods (forward-calculation from menses onset or backward-calculation from expected next menses) based on self-report alone are notoriously error-prone due to normal cycle length variability between individuals [32]. Empirical examination demonstrates that these methods result in phases being incorrectly determined for many participants, with Cohen's kappa estimates ranging from -0.13 to 0.53, indicating poor to only moderate agreement with hormonally-confirmed phases [32].

Many studies attempt to validate projected phases using ovarian hormone ranges drawn from manufacturer data or small research samples, but this approach remains problematic due to substantial between-person variability in absolute hormone levels [32]. Similarly, examining ovarian hormone changes from limited measurements (e.g., two time points) often fails to capture the dynamic, non-linear hormone fluctuations that characterize the menstrual cycle [32].

Table 1: Common Methodological Pitfalls in Menstrual Cycle Phase Determination

Method	Description	Key Limitations
Self-Report Projection (Count Methods)	Predicting phase using calendar calculations from self-reported menses onset	High error rate due to normal cycle variability; assumes prototypical 28-day cycle
Hormone Range Classification	Using standardized ovarian hormone ranges to confirm phase	Fails to account for substantial between-person variability in absolute hormone levels
Limited Hormone Sampling	Measuring hormone levels at only 1-2 time points	Insufficient to capture dynamic, non-linear hormone fluctuations across the cycle

Experimental Protocols

Comprehensive Protocol for Menstrual Cycle Phase Verification

This protocol establishes a rigorous methodology for determining menstrual cycle phase with high temporal precision, suitable for studies requiring precise phase-locked analysis.

Participant Screening and Inclusion Criteria

• Recruitment: Recruit participants aged 18-36 years with regular menstrual cycles defined as 24-38 days in length, with variation between cycles of no more than 8 days [33] [34].
• Exclusion Criteria: Exclude individuals with neurological or mental disorders, current use of psychiatric medications, chronic diseases (e.g., diabetes), irregular menstruation, or use of hormonal contraception within past 3 months [33].
• Cycle Monitoring: Participants should track their menstrual cycles for 1-2 complete cycles prior to testing to confirm regularity using a validated daily monitoring method [1].

Phase Determination and Hormonal Verification

• Menstrual Phase Testing: Schedule sessions during days 2-5 after menstruation onset, characterized by minimal levels of both estradiol and progesterone [33] [34].
• Pre-Ovulatory Phase Testing: Schedule sessions up to 2 days before expected ovulation, characterized by pronounced estradiol peak with relatively low progesterone [34].
• Hormone Confirmation: Collect blood samples via venipuncture at each testing session. Analyze estradiol, progesterone, and testosterone levels using electrochemiluminescence immunoassay (ECLIA) or similar validated method [33] [34].
• Ovulation Confirmation: For maximum precision, employ quantitative urine hormone monitoring (Mira monitor) measuring luteinizing hormone (LH) and pregnanediol glucuronide (PDG) to predict and confirm ovulation, referenced to serial ultrasounds when possible [3].

Counterbalancing and Order Effects

• When testing multiple phases within cycle, counterbalance testing order across participants to control for practice effects and familiarity with testing procedures [31].
• Maintain consistent time of day for testing sessions for each participant to control for circadian influences on dependent measures.

Protocol for Phase-Locked Cognitive Assessment

This protocol outlines a standardized approach for assessing cognitive performance across menstrual cycle phases, adaptable for drug development studies investigating cognitive side effects.

Cognitive Testing Battery

• Working Memory: Assess using Digit Span Forward and Backward tests [33] [34].
• Attention and Processing Speed: Assess using Trail Making Test A and B [33] [34].
• Executive Function: Assess using Stroop Task variants [33] [34].
• Visuospatial Abilities: Include standardized visuospatial memory and orientation tasks [33].

Testing Procedures

• Familiarization: Conduct practice sessions prior to formal testing to minimize learning effects.
• Standardized Administration: Administer tests in consistent, controlled environment with minimal distractions.
• Data Collection: Record both accuracy and response time measures for comprehensive performance assessment.

Table 2: Essential Research Reagents and Materials for Menstrual Cycle Studies

Item	Specifications	Primary Function
Electrochemiluminescence Immunoassay (ECLIA) Kits	For estradiol, progesterone, testosterone measurement	Quantitative hormone analysis from blood serum/plasma
Quantitative Urine Hormone Monitor	Mira monitor or equivalent; measures FSH, E1-3G, LH, PDG	At-home ovulation prediction and confirmation
Cognitive Testing Materials	Digit Span, Trail Making Test, Stroop Task standardized instruments	Assessment of cognitive performance across domains
Menstrual Cycle Tracking System	Validated daily symptom rating scales, bleeding logs	Prospective cycle monitoring and phase determination
Data Visualization Software	Support for CIE Luv/Lab color spaces, sequential/qualitative palettes	Creation of accessible, perceptually uniform visualizations

Data Visualization Framework for Menstrual Cycle Studies

Strategic Color Application in Phase-Locked Visualizations

Effective data visualization requires strategic color application that aligns with data type and research questions. Qualitative palettes (distinct hues) are optimal for representing categorical variables like menstrual cycle phases, where no inherent order exists between categories [35] [36]. These palettes should be limited to approximately 10 colors with deliberate hue variation to ensure visual distinction without implying quantitative significance [35].

For representing hormone levels or cognitive performance scores, sequential palettes (gradient of light to dark shades of a single hue) effectively communicate quantitative progressions and hierarchies [35]. When visualizing deviations from a baseline or contrasting conditions (e.g., pre- vs. post-intervention), diverging palettes (two contrasting hues diverging from a neutral center) effectively highlight positive and negative variations [35].

Accessibility considerations are paramount: approximately 4% of the population experiences color vision deficiency [35]. Visualization should maintain effectiveness when converted to grayscale, ensuring that luminance contrast (lightness difference) alone conveys essential information [36]. Tools like Adobe Illustrator's color blindness preview mode allow researchers to verify accessibility during design [35].

Statistical Analysis and Data Representation

For within-subject menstrual cycle data, multilevel modeling (random effects modeling) represents the most appropriate analytical approach, requiring at least three observations per person to estimate random cycle effects [1]. When visualizing results, individual spaghetti plots should be examined before group-level summaries to detect potential outliers or individual difference patterns [1].

Person-centered approaches, where an individual's mean across all observations is subtracted from each observation, help distinguish within-person cycle effects from between-person trait differences [1]. For cognitive data, visualization should capture both performance accuracy and response time measures, as these may show distinct patterns across cycle phases [33].

Experimental Protocol for Phase-Locked Menstrual Cycle Research

Visualization Framework for Menstrual Cycle Data Types

Advanced Methodological Considerations

Integrating Longitudinal and Cross-Sectional Approaches

Sophisticated menstrual cycle research can combine longitudinal within-subject designs with cross-sectional elements to address complex research questions. For example, a study might employ a longitudinal analysis comparing women's cognitive performance across menstrual and pre-ovulatory phases, while simultaneously conducting a cross-sectional analysis comparing men with women at each phase [33] [34]. This integrated approach provides insights into both within-person hormonal fluctuations and between-group sex differences within the same examination cohort.

This dual analytical strategy enables researchers to determine whether sex differences in cognitive functioning are modulated by hormonal status. Research demonstrates that sex differences in processing speed may be observed only during the menstrual phase (low estradiol) but disappear during the pre-ovulatory phase (high estradiol), highlighting the importance of accounting for cycle phase when investigating sex differences [33].

Special Considerations for Clinical and Drug Development Applications

In drug development contexts, precise menstrual cycle phase monitoring is crucial for detecting phase-dependent treatment effects or side effects. Hormone-sensitive populations such as those with premenstrual dysphoric disorder (PMDD) or premenstrual exacerbation (PME) of underlying disorders may show differential treatment responses across cycle phases [1]. Diagnostic precision requires prospective daily monitoring of symptoms for at least two consecutive menstrual cycles, as retrospective measures show poor convergence with prospective ratings [1].

Standardized diagnostic systems like the Carolina Premenstrual Assessment Scoring System (C-PASS) provide structured approaches for identifying cyclical mood disorders that might confound treatment outcome assessment [1]. For studies involving hormone manipulations or treatments that might interact with endogenous hormones, baseline cycle characterization and ongoing phase monitoring are methodologically essential.

Correlation Matrices and Heat Maps for Multi-Parameter Analysis

In the field of menstrual cycle associations research, the simultaneous analysis of multiple hormonal parameters is fundamental for understanding complex physiological interactions and their effects on brain structure and function. Correlation matrices and heat maps serve as powerful visual tools for identifying and representing these complex, multi-dimensional relationships within datasets. These visualization techniques allow researchers to move beyond univariate analysis, providing a comprehensive overview of how variables such as estradiol, progesterone, and their ratios co-vary across the menstrual cycle and relate to structural brain dynamics. This application note details the implementation of these methods specifically for menstrual cycle research, enabling the identification of potential biomarkers and therapeutic targets in drug development.

Key Hormonal Parameters and Typical Ranges

The following quantitative data, derived from densely-sampled individual studies, provides a reference for expected hormonal values and brain structural changes across different menstrual cycle types. These values are essential for contextualizing the patterns revealed in correlation analyses.

Table 1: Serum Hormone Concentrations Across Different Menstrual Cycle Types [12]

Cycle Type	Follicular Phase Estradiol (nmol l−1)	Luteal Phase Estradiol (nmol l−1)	Follicular Phase Progesterone (nmol l−1)	Luteal Phase Progesterone (nmol l−1)	Estradiol-to-Progesterone Ratio (Luteal Phase)	Cycle Length (Days)
Typical Cycle	Low, rising	Second peak	Low	>15.9 (indicating ovulation)	Typical hormonal balance	25-32
Endometriosis Cycle	-	-	-	-	Estradiol dominance	23-24
Oral Contraceptive (OC) Cycle	Comparable to natural cycle	Comparable to natural cycle	Selectively suppressed	Selectively suppressed	Estradiol dominance	-

Table 2: Whole-Brain Structural Dynamics Associated with Hormonal Fluctations [12]

Neural Metric	Associated Hormone in Typical Cycle	Associated Hormone in Endometriosis/OC Cycle	Spatial Pattern of Change
Whole-Brain Volume (VSTPs)	Progesterone levels	Estradiol levels	Widespread, coordinated changes
Cortical Thickness (CSTPs)	Progesterone levels	Estradiol levels	Widespread, coordinated changes

Experimental Protocol: Generating Correlation Matrices and Heat Maps for Menstrual Cycle Data

Data Collection and Preprocessing

• Objective: To acquire and prepare high-temporal-resolution hormonal and neuroimaging data for correlation analysis.
• Materials:
  • Participants: Females across diverse hormonal milieus (e.g., typical cycles, endometriosis, oral contraceptive use). [12]
  • Hormonal Assays: Repeated venipuncture for serum estradiol and progesterone quantification across a complete menstrual cycle. [12]
  • Neuroimaging: Daily or near-daily MRI scans (e.g., T1-weighted) for deriving structural brain metrics (e.g., volume, cortical thickness). [12]
• Procedure:
  • Dense Sampling: For each participant, conduct a minimum of 25-30 testing sessions spanning both follicular and luteal phases. [12]
  • Hormone Measurement: Process blood samples to obtain daily serum estradiol (nmol l−1) and progesterone (nmol l−1) concentrations. Calculate the estradiol-to-progesterone ratio.
  • Brain Feature Extraction: Process neuroimaging data using whole-brain analysis pipelines (e.g., voxel-based morphometry for volume, surface-based analysis for cortical thickness) to obtain daily values for regions of interest or global brain metrics. [12]
  • Data Alignment: Align all hormonal and brain structural data by cycle day, with day 1 defined as the onset of menses.
  • Data Structuring: Compile a data matrix where rows represent individual time points (days) and columns represent measured variables (e.g., Estradiol, Progesterone, Ratio, HippocampalVolume, AmygdalaVolume, GlobalGMVolume).

Correlation Analysis and Visualization

• Objective: To compute pairwise correlations between all hormonal and structural brain variables and visualize them as a heat map.
• Materials:
  • Software: Statistical programming environment (e.g., R or Python). [37]
  • Libraries/Packages:
    • R: cor() for correlation, pheatmap or ggplot2 for plotting.
    • Python: pandas for data handling, scipy.stats or numpy for correlation, seaborn or matplotlib for plotting. [37]
• Procedure:
  • Compute Correlation Matrix: Calculate a Pearson's (or Spearman's) correlation matrix from the preprocessed data matrix. The output will be a symmetric matrix where each cell [i, j] contains the correlation coefficient (r) between variable i and variable j.
  • Set Up Visualization:
    • Initialize a plotting figure with a specified size (e.g., 10x8 inches).
    • Define a color palette that is accessible and intuitively represents the data range (e.g., diverging palette from blue [negative] through white [zero] to red [positive]).
  • Generate Heat Map:
    • Plot the correlation matrix as a grid of colored squares.
    • Annotate Cells: Overlay the numerical correlation coefficient (r-value) onto each square. Optionally, include asterisks () to denote statistical significance (e.g., *p < 0.05, *p < 0.01).
    • Add Dendrograms: (Optional) Perform hierarchical clustering on the correlation matrix to group highly correlated variables together, visualized as dendrograms on the heat map axes.
  • Finalize Figure:
    • Ensure all axes are clearly labeled with variable names.
    • Add a title and a color bar (legend) explaining the color scale.

Diagram 1: Workflow for hormonal and brain data correlation analysis.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials and Tools for Menstrual Cycle Multi-Parameter Analysis

Item Name	Function/Benefit in Analysis	Example/Specification
Statistical Programming Language (R/Python)	Provides a flexible, reproducible environment for data wrangling, statistical computation (correlation matrices), and custom visualization (heat maps). [37]	R (with pheatmap, ggplot2), Python (with pandas, seaborn, matplotlib). [37]
Hormonal Assay Kits	Quantifies serum concentrations of key gonadal hormones (estradiol, progesterone) from participant blood samples with high precision. [12]	Commercial immunoassay kits, Mass spectrometry.
Structural Neuroimaging Pipeline	Processes raw MRI data into quantifiable metrics of brain structure (e.g., regional volumes, cortical thickness) for correlation with hormonal data. [12]	Freesurfer, FSL, SPM, CAT12.
Data Visualization Software/Libraries	Enables the creation of publication-quality, accessible heat maps and correlation matrices for data interpretation and communication. [37]	Tableau, Power BI, R ggplot2, Python seaborn. [37]
Accessible Color Palette	Ensures visualizations are interpretable by all users, including those with color vision deficiencies, and compliant with accessibility standards. [38] [7] [39]	WCAG 2.1 AA compliant palettes; sufficient contrast (≥4.5:1 for text).

Visualization Implementation with Accessible Color Contrast

Adherence to color contrast guidelines is critical for creating inclusive and legally compliant scientific communications. The following diagram illustrates the logical decision process for applying an accessible color scheme to a heat map, using the specified color palette.

Diagram 2: Logic for applying accessible color contrast in heat map design.

The integration of wearable technology in clinical and research settings provides an unprecedented opportunity to capture high-density physiological data in real-world contexts [40]. For research exploring associations with the menstrual cycle, this continuous data stream offers a quantitative means to investigate physiological fluctuations and their correlations with cyclic phases [41]. However, the raw volume and complexity of data from devices—encompassing heart rate (HR), skin temperature, and Heart Rate Variability (HRV)—present significant challenges in data aggregation, standardization, and interpretation [41] [40]. The effective visualization of this data is not merely a final presentation step but a critical analytical process that can reveal patterns, trends, and outliers essential for generating robust scientific insights [42]. This document outlines application notes and detailed protocols for the management, analysis, and visualization of high-density wearable data, framed within the specific requirements of menstrual cycle associations research.

Data from wearable devices can be broadly categorized into raw signal data and derived metrics. The table below summarizes the core quantitative data types relevant to menstrual cycle research.

Table 1: Core Quantitative Data Streams from Wearable Devices

Data Stream	Description & Units	Common Sampling Frequency	Relevance to Menstrual Cycle Research
Heart Rate (HR)	Beats per minute (BPM); typically measured via photoplethysmography (PPG) [40].	1 sec to 1 min intervals	Can track resting heart rate trends, which may fluctuate across phases [40].
Heart Rate Variability (HRV)	A measure of autonomic nervous system function. Common metrics include RMSSD (ms), SDNN (ms), and LF/HF ratio [40].	1-5 min epochs (from beat-to-beat data)	A key marker of stress and recovery; potential variations linked to hormonal changes.
Skin Temperature	Degrees Celsius (°C) or Fahrenheit (°F); measured by a skin-contact sensor.	1-5 min intervals	May show a biphasic pattern, with a slight rise after ovulation.
Sleep Stages	Categorical data (Wake, Light, Deep, REM); derived from HR, HRV, movement, and temperature [40].	Nightly summaries	Sleep architecture and quality can be significantly impacted by menstrual cycle phases.
Activity/Steps	Count of steps or activity units (e.g., metabolic equivalents).	Continuous or in minute-level bins	Useful as a covariate to control for the effect of physical exertion on HR and HRV.

The process of transforming this raw data into actionable insights involves multiple stages, from collection to visualization, as outlined in the workflow below.

Experimental Protocols for Data Management and Analysis

Protocol: Data Collection and Preprocessing

Objective: To ensure the collection of high-fidelity, raw data from wearable devices and perform essential preprocessing to prepare it for analysis [43].

Materials:

• Consumer-grade wearable device (e.g., Fitbit, Apple Watch, Garmin) or research-grade sensor.
• Cloud infrastructure or local server for secure data storage.
• Data processing software (e.g., Python with Pandas, R).

Methodology:

• Device Selection and Configuration: Select devices that provide access to raw or minimally processed data streams (e.g., beat-to-beat intervals for HRV) rather than only nightly summaries [41]. Standardize device type and firmware versions across the study cohort to minimize variability.
• Data Extraction and Ingestion: Use manufacturer Application Programming Interfaces (APIs) to extract data. Store all data with timestamps in Coordinated Universal Time (UTC) to prevent timezone-related errors.
• Data Cleaning and Imputation:
  • Handling Missing Data: Identify gaps in data collection. For short gaps (e.g., <1 hour), consider imputation methods such as linear interpolation. For longer gaps, flag the data and consider exclusion from minute-level analysis [43].
  • Identifying and Treating Outliers: Use statistical methods (e.g., Z-scores, Interquartile Range) to detect physiologically implausible values (e.g., HR < 30 or >220 BPM at rest). These values can be removed or winsorized.
  • Signal Quality Indication: Where possible, incorporate signal quality indices from the device to label low-quality data periods for potential exclusion.

Protocol: Temporal Aggregation and Menstrual Cycle Alignment

Objective: To transform continuous time-series data into phase-specific aggregates that facilitate cycle-level analysis.

Materials:

• Preprocessed, timestamped data for HR, HRV, and temperature.
• Self-reported menstrual cycle tracking data (start date of menses, cycle length).
• Computational environment for time-series analysis (e.g., Python, R).

Methodology:

• Cycle Phase Definition: Based on the first day of menses, define phases for each participant. A common model is:
  • Menstrual Phase: Days 1-5.
  • Follicular Phase: Days 6-13 (or until ovulation confirmation).
  • Ovulatory Phase: ~Day 14 (can be adjusted based on LH tests or temperature shift).
  • Luteal Phase: Day 15 until the start of next menses.
• Data Aggregation: For each physiological variable and for each cycle phase, calculate summary statistics. This reduces the high-density data into manageable, phase-level features.
• Create Summary Table: Structure the aggregated data for statistical testing and visualization.

Table 2: Example of Phase-Aggregated Data Structure

Participant ID	Cycle ID	Phase	Mean RHR (bpm)	Mean Nocturnal RMSSD (ms)	Mean Sleep Temp (°C)	Phase Duration (Days)
P-001	C-1	Menstrual	58.2	42.5	36.12	5
P-001	C-1	Follicular	56.8	45.1	36.05	8
P-001	C-1	Ovulatory	56.1	44.8	36.09	1
P-001	C-1	Luteal	57.5	41.2	36.21	14
P-002	C-1	Menstrual	62.1	38.2	36.35	4

Data Visualization Techniques and Workflows

Effective visualization is key to exploring and communicating patterns in high-density wearable data. The following workflows and corresponding diagrams detail the process for creating standard visualizations.

Workflow: Creating a Multi-Panel Time-Series Plot

This visualization allows for the concurrent examination of multiple data streams over time, synchronized with menstrual cycle phases.

Workflow: Creating a Cyclical Averages Plot

This plot is essential for identifying consistent, phase-locked physiological patterns across multiple cycles.

The Scientist's Toolkit: Essential Research Reagents and Solutions

Table 3: Key Resources for Wearable Data Research in Menstrual Science

Item	Function & Application	Example/Specification
Consumer Wearables (FDA-cleared)	Provides continuous, passive data collection in free-living conditions. Essential for ecological momentary assessment (EMA) study designs.	Devices with validated HR/HRV metrics (e.g., specific Apple Watch, Fitbit, Garmin models) [40].
Research-Grade Actigraphs	High-precision devices for measuring sleep-wake patterns and activity, often considered a gold standard in research settings.	Devices from manufacturers like ActiGraph, validated against polysomnography.
Cloud Data Platform	Secure, scalable infrastructure for ingesting, storing, and processing high-volume time-series data from multiple participants.	AWS HealthLake, Google Cloud Platform, or Azure Health Data Services, configured for HIPAA compliance [44].
Computational Environment	Software and libraries for data wrangling, statistical analysis, and generating publication-quality visualizations.	Python (Pandas, NumPy, SciPy, Matplotlib, Seaborn) or R (tidyverse, ggplot2) [42] [43].
Menstrual Cycle Tracking Module	A standardized digital tool for participants to self-report cycle start dates and symptoms, ensuring consistent metadata.	Integrated into a study-specific mobile app or a secure web portal.
Data Standardization Schema	A predefined data structure (e.g., using JSON or Parquet formats) to harmonize data from different sources, as advocated by NIMH [41].	A schema defining field names, units, and timestamps for all data streams, promoting reusability.

Application Notes

Quantitative Data on Tracking Method Performance

Table 1: Performance Metrics of Ovulation and Luteal Phase Tracking Methods

Tracking Method	Key Measured Parameter	Typical Accuracy / Correlation with LH Peak	Phase Detection Error (Days)	Key Advantages	Key Limitations
Quantitative BBT (Least Mean Square Method) [45]	Basal Body Temperature Shift	r = 0.879 (vs. LH peak)	+2.4 ± 1.5	Reliable for population-level luteal phase length documentation [45]; Low cost [46]	Susceptible to sleep timing disruptions [13]; Confirms ovulation post-event [46]
Circadian Rhythm minHR (Machine Learning) [13]	Heart Rate at Circadian Nadir	Significantly improves luteal phase classification vs. "day-only" models [13]	Reduces absolute error by ~2 days vs. BBT in high sleep variability [13]	Robust to variable sleep schedules; Practical in free-living conditions [13]	Requires specialized model (e.g., XGBoost) and data collection [13]
Urine Hormone Tests (OPKs) [46]	Luteinizing Hormone (LH) Surge	~95% accuracy predicting ovulation within 24-36 hours with 10 days of testing [46]	Predicts ovulation prior to event	High accuracy for predicting imminent ovulation [46]	Does not confirm ovulation occurred or luteal phase health [47]; Cost of kits [27]
Cervical Mucus Method [46]	Consistency and Appearance (e.g., egg-white)	~96-97% accuracy in determining fertility when used correctly [46]	N/A	Provides direct biological indication of fertility [46]	Subjective; Confounded by infections, medications, or douching [46]
Symptothermal Method (Combined) [46]	BBT + Cervical Mucus + Calendar	Up to 99.6% efficacy rate when methods are combined [46]	N/A	Highest accuracy among natural methods; Cross-verification between signs [46]	Requires significant education and daily discipline [46]

Table 2: Physiological Parameters Across Menstrual Cycle Phases

Cycle Phase / Day	Hormonal Milestones	Physiological Correlates	Cognitive/Motor Performance (Example Data)
Early Follicular (Day 1) [48]	Low Estrogen, Low Progesterone [47]	Menstruation; Endometrial shedding [47]	Baseline Auditory Reaction Time (ART): ~211 ms [48]
Mid-Follicular (Day 7) [48]	Rising Estrogen [47]	Endometrial proliferation [47]	ART: ~226 ms [48]
Ovulatory (Day 14) [48]	LH and FSH Surge; High Estrogen [47]	Cervical mucus becomes clear and stretchy; Ovum release [47] [46]	Slowest ART: ~233 ms; Slowest Visual Reaction Time (VRT): ~258 ms [48]
Mid-Luteal (Day 21) [48]	High Progesterone, High Estrogen [47]	Elevated BBT; Endometrial secretion [47] [46]	Fastest ART: ~191 ms; Fastest VRT: ~209 ms [48]

Key Data Visualization Challenges and Solutions

Visualizing menstrual cycle data presents unique challenges, including the need to represent cyclical patterns, multi-dimensional data (hormones, symptoms, physiological markers), and individual variability. Effective color palettes are critical for clarity and accessibility [20] [26]. The specified color palette (#4285F4, #EA4335, #FBBC05, #34A853, #FFFFFF, #F1F3F4, #202124, #5F6368) provides a foundation for creating such visualizations, adhering to principles of contrast and intuitive encoding [20].

Experimental Protocols

Protocol: Machine Learning Model for Cycle Phase Classification Using minHR

Objective: To classify menstrual cycle phases and predict ovulation day using a machine learning model (XGBoost) trained on heart rate at the circadian rhythm nadir (minHR) under free-living conditions [13].

Materials:

• Healthy female participants (e.g., aged 18-34) [13].
• Wearable device capable of continuous heart rate monitoring.
• Data processing and machine learning software (e.g., Python, R).
• Validation metric: mid-cycle LH peak via urine tests or serum assay [13].

Procedure:

• Data Collection: Recruit participants and collect data over multiple menstrual cycles (e.g., up to 3 cycles). Collect continuous heart rate data and self-reported sleep onset/offset times.
• Feature Extraction: For each participant and day, calculate the minHR feature. The "day" feature (days since menstruation onset) should also be included [13].
• Model Training & Evaluation:
  • Utilize a nested leave-one-group-out cross-validation strategy to prevent overfitting and ensure robust performance estimation [13].
  • Train an XGBoost model using different feature combinations (e.g., "day", "day + minHR", "day + BBT").
  • Stratify participants based on sleep timing variability (high vs. low).
  • Assess model performance using metrics such as luteal phase recall and the mean absolute error in predicting the ovulation day compared to the LH peak reference [13].

Protocol: Validation of Luteal Phase Length via Quantitative BBT

Objective: To determine luteal phase onset and length from basal body temperature data using quantitative methods and validate against the mid-cycle LH peak [45].

Materials:

• High-resolution digital basal thermometer (precision ±0.01°C).
• BBT charting application or logbook.
• LH surge detection kits or access to serum LH testing.
• Algorithm for quantitative BBT analysis (e.g., Least Mean Square, Mean Temperature, Cumulative Sum) [45].

Procedure:

• BBT Measurement: Participants take their temperature orally or rectally immediately upon waking, before any physical activity, and record it daily throughout the cycle [46].
• LH Peak Determination: Identify the day of the LH peak using daily urine tests or serum assays [47].
• Luteal Phase Onset Analysis:
  • Apply quantitative methods (e.g., Least Mean Square) to the BBT series to identify the day of the thermal shift marking luteal phase onset.
  • The Least Mean Square method fits a curve to the data, with the luteal onset defined by the intersection of follicular and luteal regression lines [45].
• Validation: Calculate the correlation coefficient and the mean delay (with standard deviation) between the identified BBT thermal shift day and the actual LH peak day for each quantitative method [45].

Protocol: Auditory and Visual Reaction Time Across the Menstrual Cycle

Objective: To quantify variations in psychomotor function by measuring Auditory (ART) and Visual (VRT) Reaction Times at specific points in the menstrual cycle [48].

Materials:

• Audiovisual Reaction Time Apparatus (e.g., Medisystem, 100% display accuracy, 0.1s resolution) [48].
• Quiet testing room.
• Participant log with cycle day and confirmation of regular cycles.

Procedure:

• Participant Preparation: Recruit healthy females with regular menstrual cycles (28 ± 2 days). Exclude participants with conditions or habits that may affect reaction times. Testing should occur in the morning after a light breakfast without stimulants [48].
• Testing Schedule: Schedule reaction time tests on target days: Day 1 (menstruation), Day 7 (mid-follicular), Day 14 (estimated ovulation), and Day 21 (mid-luteal) [48].
• Measurement:
  • For each session, conduct three practice trials followed by three recorded trials for both ART (high-frequency tone) and VRT (red light).
  • The participant deactivates the stimulus as quickly as possible. The apparatus records the time interval between stimulus onset and response.
• Data Analysis: Use the lowest value from the three trials as the final ART/VRT for that session. Analyze data using ANOVA with post-hoc tests (e.g., Tukey HSD) to compare mean differences in ART/VRT across the four test days [48].

Mandatory Visualization

Diagram: Menstrual Cycle Hormonal Signaling & Key Tracking Markers

Diagram: Experimental Protocol for Combined Tracking & Validation

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for Menstrual Cycle Tracking Research

Item / Reagent	Function in Research	Example Application / Note
Urine Luteinizing Hormone (LH) Detection Kits	Gold-standard reference for pinpointing the imminent ovulation event (LH surge) in validation studies [47] [46].	Used daily around the expected fertile window to detect the surge 24-36 hours pre-ovulation [46]. Critical for validating other tracking methods [13] [45].
High-Resolution Digital Thermometer	Captures subtle, progesterone-mediated shifts in Basal Body Temperature (BBT) to confirm ovulation and luteal phase onset retrospectively [46].	Must have precision to at least 0.1°F or 0.01°C. Used for quantitative BBT analysis methods (e.g., Least Mean Square) [45].
Consumer Wearable Devices (HR/Sleep)	Enables continuous, free-living data collection on physiological parameters like heart rate and sleep patterns for modern computational approaches [13].	Provides data for features like heart rate at circadian nadir (minHR). Key for machine learning models that are robust to sleep variability [13].
Cervical Mucus Observation Chart	Standardizes the qualitative recording of cervical mucus changes, a primary biomarker of estrogenic activity and fertility [46].	Used in the Cervical Mucus Method and Symptothermal Method. Requires participant training to accurately identify "egg-white" fertile mucus [46].
Reaction Time Apparatus	Quantifies psychomotor performance variations linked to hormonal fluctuations across the cycle, providing an objective functional correlate [48].	Measures Auditory (ART) and Visual (VRT) Reaction Times. Devices like the Medisystem apparatus offer high accuracy and resolution [48].
Machine Learning Algorithms (e.g., XGBoost)	Analyzes complex, multi-parameter datasets (e.g., minHR, day of cycle) to classify cycle phases and predict ovulation with high precision [13].	Outperforms traditional methods like BBT in specific populations (e.g., individuals with high sleep variability) [13].

Navigating Pitfalls: Optimizing Visuals for Complex and Messy Cycle Data

Quantitative Data on Phase Length Variability

Prospective 1-year data from 53 premenopausal women provides key quantitative insights into within-woman and between-women variability of follicular and luteal phase lengths [49].

Table 1: Menstrual Cycle Phase Length Variance (1-Year Prospective Data) [49]

Measure	Overall Cycle (53 women, 676 cycles)	Within-Woman Median Variance
Menstrual Cycle Length	10.3 days variance	3.1 days variance
Follicular Phase Length	11.2 days variance	5.2 days variance
Luteal Phase Length	4.3 days variance	3.0 days variance

Table 2: Comparative Phase Length Ranges in Premenopausal Women [49]

Phase	Reported Ranges in Literature	Common Clinical Assumption
Follicular Phase	10-23 days [49], 12.9 days (95% CI 8.2–20.5 days) [49], 14.7 days (±2.4 days) [49]	Highly variable
Luteal Phase	7-15 days [49], 11.3–17.0 days [49], 12.4±2.0 days [49]	Fixed at 13-14 days

Experimental Protocols for Phase Length Determination

Purpose: To accurately determine follicular and luteal phase lengths through daily monitoring and temperature analysis.

Population Criteria:

• Healthy, non-smoking, normal BMI (18.5-24.9) women
• Ages 21-41 years
• Documented history of two normal-length (21-36 days) and normally ovulatory (≥10 days luteal phase) menstrual cycles prior to enrollment

Materials:

• Menstrual Cycle Diary for daily recording
• Digital basal thermometer (accuracy ±0.05°C)
• QBT analysis software
• Standardized time measurement for first morning temperature

Procedure:

• Participants record first morning temperature immediately upon waking, before any physical activity
• Document exercise duration, intensity, and timing
• Record menstrual flow characteristics and life experiences daily
• Continue daily tracking for 12 consecutive menstrual cycles
• Analyze temperature data using validated least-squares QBT method to identify biphasic pattern
• Define ovulation day as the point of maximum curvature in the temperature curve
• Calculate follicular phase length: day 1 of menses to day before ovulation
• Calculate luteal phase length: ovulation day to day before next menses

Quality Control:

• Exclude cycles with incomplete temperature data (>20% missing days)
• Validate QBT results with urinary LH surge detection in subset of cycles
• Classify cycles with luteal phase <10 days as subclinical ovulatory disturbances (SOD)

Purpose: To validate non-invasive salivary and urinary methods for detecting menstrual cycle hormones and identifying phase transitions compared to gold standard methods.

Sample Collection:

• Salivary estradiol and progesterone: Passive drool collection between 7-9 AM after overnight fast
• Urinary luteinizing hormone: First morning void collected in sterile containers
• Frequency: Daily sampling throughout complete menstrual cycle
• Storage: -80°C until batch analysis

Analysis Methodology:

• Salivary hormones: Enzyme immunoassay with sensitivity ≤1.0 pg/mL for estradiol, ≤10 pg/mL for progesterone
• Urinary LH: Immunochromatographic dipstick tests with visual readout and digital readers
• Validation against serum LH, transvaginal ultrasound (gold standards)
• Intra-assay coefficient of variation calculation for precision assessment

Phase Definition Criteria:

• Early follicular: Cycle day 3 ±1 day [50]
• Peri-ovulatory: Ultrasound day of ovulation ±1 day [50]
• Luteal phase: Ultrasound day of ovulation +5, +7, +9 days [50]

Data Visualization Framework for Cycle Variability

Research Reagent Solutions

Table 3: Essential Materials for Menstrual Cycle Phase Research

Category	Specific Item	Function/Application
Hormone Detection	Salivary Estradiol EIA Kit [50]	Measures bioavailable estradiol for follicular phase monitoring
	Salivary Progesterone EIA Kit [50]	Assesses luteal phase adequacy and ovulation confirmation
	Urinary LH Immunoassay Strips [50]	Detects LH surge for ovulation timing
Cycle Monitoring	Quantitative Basal Temperature System [49]	Identifies biphasic pattern for ovulation detection
	Menstrual Cycle Diary [49]	Documents symptoms, timing, and life experiences
Validation Methods	Transvaginal Ultrasound [50]	Gold standard for follicular growth and ovulation
	Serum Hormone Panels [50]	Reference method for hormone assay validation
Data Analysis	QBT Analysis Software [49]	Calculates phase lengths using least-squares algorithm
	Statistical Packages (R, SPSS)	Analyzes within-woman and between-women variance

Clinical and Research Implications

The documented variability in both follicular and luteal phases challenges the conventional assumption of a fixed 13-14 day luteal phase [49]. Within-woman variances of 5.2 days for follicular phase and 3.0 days for luteal phase highlight the importance of longitudinal assessment rather than single-cycle measurements [49]. The high prevalence of subclinical ovulatory disturbances (55% experiencing short luteal phases, 17% anovulatory cycles) within normal-length cycles underscores the limitation of relying solely on cycle regularity as a marker of ovulatory function [49]. These findings have significant implications for fertility research, drug development targeting reproductive hormones, and the design of clinical trials involving menstruating women.

Mitigating Selection Bias and Generalizability Limits in Study Samples

In menstrual cycle research, selection bias and challenges to generalizability can occur through multiple mechanisms, potentially compromising the validity and applicability of study findings. These biases often stem from the methods of participant recruitment, the use of specific menstrual tracking technologies, and the focus on particular sub-populations, such as those trying to conceive [51]. Furthermore, the absence of standardized methods for operationalizing the menstrual cycle across different laboratories has resulted in substantial confusion in the literature and limited possibilities for systematic reviews and meta-analyses [1] [28]. This document outlines practical protocols and data visualization strategies to identify, mitigate, and report these limitations, with a specific focus on research investigating associations with the menstrual cycle.

The following tables summarize key quantitative data and methodological considerations for assessing selection bias and generalizability in menstrual cycle studies.

Table 1: Common Sources of Selection Bias and Their Impact in Menstrual Cycle Research

Source of Bias	Description	Potential Impact on Study Findings
Recruitment of Women Trying to Conceive [51]	Women contribute cycles only until pregnancy; women with less fertile cycles contribute more data (informative cluster size).	Over-representation of menstrual cycle characteristics associated with subfertility; biased associations.
Use of Cycle Tracking Apps [51]	Apps may have fees, specific OS requirements, and unique user demographics (e.g., predominantly White user-base).	Results may not generalize to populations of different socioeconomic, racial, or ethnic backgrounds.
Focus on "Regular Cycles" [51]	Studies often require regular cycles for enrollment, or rely on fertility awareness methods designed for predictable cycles.	Exclusion of women with irregular cycles, limiting understanding of cycle variability and associated health outcomes.
Volunteer Bias [51]	Women who volunteer for cycle studies may have a greater interest in their cycles, potentially due to perceived irregularities.	Over-estimation of symptom prevalence or cycle irregularity in the broader population.
Assumed vs. Measured Cycle Phases [52]	Using calendar-based estimates of menstrual cycle phases instead of direct hormonal or physiological measurements.	Significant misclassification of cycle phase; invalid data on hormone-performance or health relationships.

Table 2: Recommended Direct Measurements for Eumenorrheic Cycle Characterization

Parameter	Measurement Method	Purpose and Rationale
Menstrual Bleeding Dates [1]	Participant self-report of onset of menstrual bleeding.	Defines cycle day 1; essential for forward-count dating of the early follicular phase.
Urinary Luteinizing Hormone (LH) [1] [52]	At-home ovulation test kits (qualitative) or quantitative immunoassays.	Identifies the LH surge, which precedes ovulation by ~24-48 hours; critical for pinpointing the start of the luteal phase.
Serum or Salivary Progesterone [1] [52]	Immunoassays of blood or saliva samples collected during the mid-luteal phase.	Confirms that ovulation has occurred and a hormonally active corpus luteum is present.
Estradiol (E2) Levels [1]	Immunoassays of blood or saliva samples at multiple time points.	Helps characterize the hormonal profile across different cycle phases (e.g., periovulatory E2 peak).

Experimental Protocols for Mitigating Bias

Protocol for Participant Recruitment and Characterization

Objective: To recruit a sample that is representative of the target population and to characterize it thoroughly to assess generalizability.

• Minimize Exclusion Criteria: Justify all exclusion criteria (e.g., hormonal contraceptive use, known subfertility) scientifically rather than for convenience. Report the number and characteristics of excluded individuals [53].
• Stratified Recruitment: If using app-based data, report the app's name, cost, operating system requirements, and its known user demographics. Actively recruit through diverse channels (e.g., community centers, universities, multiple online platforms) to oversample underrepresented racial, ethnic, and socioeconomic groups [51].
• Document Pregnancy Intentions: Collect data on pregnancy intentions and contraceptive use at enrollment and, in longitudinal studies, at each cycle. This allows for analysis of cycles from women not actively trying to conceive, mitigating a key source of selection bias [51].
• Report Cycle Regularity: Do not exclude women with irregular cycles. Instead, document cycle history and include cycle regularity as a covariate or effect modifier in analyses [51].

Protocol for Menstrual Cycle Phase Determination

Objective: To move beyond assumed or estimated cycle phases and use direct measurements for valid phase classification [52].

• Define Cycle Start: Instruct participants to report the first day of menstrual bleeding (spotting does not count) as Cycle Day 1 [1].
• Identify Ovulation:
  • Provide participants with at-home urinary LH test kits.
  • Instruct them to begin testing daily from approximately Cycle Day 10 until a surge is detected.
  • The day of the LH surge is designated as the day of ovulation for phase calculation purposes [1].
• Confirm Luteal Phase:
  • Schedule a laboratory visit for the mid-luteal phase (approximately 7 days after the detected LH surge).
  • Collect a blood or saliva sample for progesterone analysis.
  • Confirm a luteal phase by a progesterone level exceeding a pre-specified threshold (e.g., >5 ng/mL in serum) [52].
• Phase Calculation:
  • Follicular Phase: Cycle Day 1 to the day of the LH surge.
  • Luteal Phase: The day after the LH surge to the day before the next menstrual bleed [1].

Data Visualization Strategies for Assessing Bias and Cycle Associations

Effective data visualization is critical for exploring data, identifying patterns, and communicating findings related to the menstrual cycle and potential biases.

Table 3: Data Visualization Techniques for Menstrual Cycle Research

Visualization Type	Application in Menstrual Cycle Research	Example Use Case
Spaghetti Plot [1]	Visualizing within-participant changes in a variable (e.g., symptom severity) across the cycle for each individual in the sample.	Identifying outliers and understanding individual differences in cyclical patterns.
Scatter Plot [54] [55]	Observing the relationship between two continuous variables (e.g., estradiol level and cognitive test score).	Assessing raw, unadjusted associations between hormonal levels and outcomes.
Box and Whisker Plot [55]	Comparing the distribution of a quantitative outcome (e.g., luteal phase length) between groups (e.g., different recruitment sources).	Identifying differences in cycle characteristics between sub-samples, suggesting potential selection bias.
Correlation Matrix (Correlogram) [54] [55]	Displaying correlation coefficients between multiple continuous variables (e.g., hormone levels, cycle length, age, BMI).	Quickly summarizing the strength and direction of relationships among a large set of variables.
Bar Chart [56] [55]	Comparing a quantitative variable (e.g., mean participant age) or a frequency (e.g., racial distribution) across categorical groups.	Illustrating demographic differences between the study sample and the target population.

Visualizing Phase Determination and Data Analysis Workflows

The following diagrams, created using Graphviz, illustrate key experimental and analytical workflows.

Visualizing Statistical Modeling Approaches for Cyclical Data

The Scientist's Toolkit: Research Reagent Solutions

Table 4: Essential Materials and Reagents for Menstrual Cycle Research

Item	Function and Application in Research
Urinary Luteinizing Hormone (LH) Test Kits [1]	At-home qualitative tests used by participants to detect the LH surge, enabling identification of ovulation and demarcation of follicular and luteal phases.
Enzyme-Linked Immunosorbent Assay (ELISA) Kits	For quantitative analysis of steroid hormones (e.g., progesterone, estradiol) in serum, saliva, or urine samples to confirm ovulatory cycles and define hormonal milieus.
Electronic Basal Body Temperature (BBT) Monitors [1]	Devices that track the slight rise in resting body temperature following ovulation; a proxy, though less precise than LH kits, for confirming the luteal phase.
Menstrual Cycle Tracking Apps with Data Export [51]	Software applications that facilitate dense, longitudinal data collection on bleeding, symptoms, and other user inputs. A source of large-scale, real-world data.
Statistical Software (R, Python, SAS) [1]	Platforms capable of running multilevel modeling (mixed-effects models) to appropriately handle repeated, within-person measurements across the cycle.

Best Practices for Color Palettes and Visual Encoding in Cycle Data

In menstrual cycle associations research, effective data visualization is paramount for accurately communicating complex hormonal patterns, symptom fluctuations, and temporal relationships. The cyclical nature of menstrual data—characterized by repeating phases, changing hormone levels, and within-subject variability—demands specialized visualization approaches that standard chart types may not adequately address. Proper visual encoding ensures that research findings are communicated clearly, accurately, and accessibly to diverse audiences including researchers, clinicians, and drug development professionals. This protocol establishes comprehensive guidelines for color palettes and visual encoding strategies specifically optimized for menstrual cycle research data visualization, integrating established data visualization principles with domain-specific requirements for reproductive science.

Color Palette Specifications for Cycle Data

Core Color Palette for Menstrual Cycle Research

Table 1: Recommended Color Palette for Menstrual Cycle Data Visualization

Color Name	Hex Code	Recommended Usage	Accessibility Consideration
Primary Blue	#4285F4	Follicular phase, estrogen dominance	Sufficient contrast against white
Accent Red	#EA4335	Menstrual phase, alert data points	Avoid pairing with green for colorblind
Highlight Yellow	#FBBC05	Ovulatory surge, key findings	Use sparingly for emphasis
Confirmation Green	#34A853	Luteal phase, positive indicators	Test for deuteranopia compatibility
Pure White	#FFFFFF	Backgrounds, negative space	Ensure contrast with adjacent colors
Light Grey	#F1F3F4	Gridlines, secondary elements	Maintain subtlety while remaining visible
Text Black	#202124	Primary text, essential labels	High contrast against light backgrounds
Medium Grey	#5F6368	Secondary text, less critical elements	Readable but receding appearance

Application-Specific Color Schemes

Phase-Specific Encoding: Assign distinct hues to menstrual cycle phases to create immediate visual recognition [1]. Use Primary Blue (#4285F4) for follicular phase, Confirmation Green (#34A853) for luteal phase, and Accent Red (#EA4335) for menstrual phase. The ovulatory window may be highlighted with Highlight Yellow (#FBBC05) to denote its transitional nature.

Hormone Concentration Gradients: Implement sequential color schemes for representing hormone concentration levels [20]. For estradiol, use a light-to-dark gradient of a single hue (e.g., light #F1F3F4 to dark #4285F4). Progesterone may use a different hue family (e.g., light #F1F3F4 to dark #34A853). Ensure gradient progression moves logically from light colors for low values to dark colors for high values [20].

Symptom Severity Encoding: Use a diverging color palette to represent symptom intensity relative to baseline [20]. For example, use #EA4335 for severe symptoms, #FBBC05 for moderate, #F1F3F4 for baseline, and #34A853 for improved states. This approach effectively communicates deviation from normal ranges.

Visual Encoding Principles for Cycle Data

Data Type and Visual Variable Mapping

Table 2: Visual Encoding Selection Guide for Cycle Data Types

Data Type	Recommended Visual Variables	Cycle Research Examples	Avoid
Quantitative	Position, size, color value	Hormone levels, temperature	Color hue, shape
Ordered/Qualitative	Color value, position, size	Symptom severity scales	Texture, orientation
Categorical	Color hue, shape, position	Cycle phases, symptom types	Size, color value

Menstrual Cycle-Specific Encoding Strategies

Temporal Encoding: Represent cycle days consistently along the x-axis, with day 1 always indicating the first day of menstrual bleeding [1]. Use consistent scaling across visualizations to facilitate comparison. For longitudinal studies spanning multiple cycles, consider a circular layout or small multiples arrangement to preserve cyclical patterns.

Within-Subject Variability: Display individual trajectories using spaghetti plots with a consistent color scheme across participants [1]. Overlay group averages with emphasized line weight and distinct color. This approach acknowledges the significant between-person differences in cycle characteristics and symptom experiences [1].

Phase Delineation: Visually distinguish menstrual cycle phases using subtle background shading or vertical demarcations. Maintain consistent phase definitions across all study visualizations: follicular phase (day 1 through ovulation), luteal phase (post-ovulation through day before next menses) [1].

Experimental Protocols for Visualization Implementation

Protocol 1: Creating Spaghetti Plots for Individual Cycle Trajectories

Purpose: Visualize within-subject changes across the menstrual cycle while maintaining individual patterns.

Materials and Reagents:

• Time-series data with cycle day and outcome variable
• Statistical software (R, Python, or equivalent)
• Color palette per Section 2.0

Procedure:

• Calculate cycle day for each observation using forward-count (days 1-10) and backward-count methods from subsequent monset [1]
• Person-center outcome data by subtracting individual's mean from each observation [1]
• Plot person-centered outcome against cycle day for each participant
• Use Primary Blue (#4285F4) at 30% opacity for individual trajectories
• Overlay group average trajectory using Accent Red (#EA4335) at 100% opacity with 2pt line weight
• Add vertical lines at key phase transitions (ovulation, phase boundaries)
• Apply consistent axis limits across all comparable plots
• Label phases with background shading using light colors from palette (#F1F3F4 variations)

Quality Control: Verify that at least 70% of individual data points are visible behind average trajectory. Ensure legend clearly distinguishes between individual and group-level patterns.

Protocol 2: Hormone Concentration Visualization with Dual Y-Axes

Purpose: Display multiple hormone trajectories on a shared temporal axis while maintaining readability.

Materials and Reagents:

• Hormone assay data (estradiol, progesterone, LH) aligned by cycle day
• Visualization software with dual-axis capability
• Color palette per Section 2.0

Procedure:

• Align all hormone data by cycle day using confirmed ovulation as reference point [1]
• Plot estradiol using Primary Blue (#4285F4) on primary Y-axis
• Plot progesterone using Confirmation Green (#34A853) on secondary Y-axis
• Add luteinizing hormone (LH) surge using Highlight Yellow (#FBBC05) as vertical line or point overlay
• Use line styles to differentiate hormones (solid for estradiol, dashed for progesterone)
• Include cycle phase background shading per Protocol 1, Step 8
• Add annotation for ovulation window using Highlight Yellow (#FBBC05) background
• Apply clear axis labels with units and hormone names in corresponding colors

Quality Control: Verify that secondary axis scaling does not misrepresent hormone relationships. Include correlation statistics in caption when appropriate.

Diagrammatic Representations

Experimental Workflow for Cycle Data Visualization

Color Selection Decision Framework

Research Reagent Solutions

Table 3: Essential Materials for Menstrual Cycle Visualization Research

Reagent/Resource	Function	Specification	Application Notes
Carolina Premenstrual Assessment Scoring System (C-PASS)	Standardized symptom assessment	Worksheet, Excel macro, R/SAS macros	Required for PMDD/PME diagnosis; ensures consistent symptom quantification [1]
Luteinizing Hormone (LH) Surge Tests	Ovulation confirmation	Urinary dipstick, digital reader	Determines luteal phase start date; critical for phase alignment [1]
Basal Body Temperature (BBT) Kits	Ovulation detection	Digital thermometer (0.01°C precision)	Secondary method for ovulation confirmation; requires consistent morning measurement [1]
Salivary Hormone Assays	Non-invasive hormone monitoring	ELISA kits for E2, P4	Validated alternative to serum measurements for frequent sampling [1]
Color Accessibility Tools	Colorblind-safe verification	Online contrast checkers, simulation tools	Essential for ensuring visualizations are accessible to all researchers [20]
Data Visualization Libraries	Code-based visualization	ggplot2 (R), Matplotlib/Seaborn (Python)	Enables consistent implementation of color palettes and encoding strategies [9]

Techniques for Visualizing and Handling Missing Data and Outliers

In the field of menstrual cycle associations research, data quality is paramount for drawing valid conclusions about the complex interplay between ovarian hormones, physiological markers, and behavioral outcomes. The integrity of research findings in this domain heavily depends on rigorous preprocessing of data, particularly the handling of missing observations and anomalous data points that may represent measurement error, biological variability, or pathological states. This protocol provides standardized methodologies for identifying, visualizing, and addressing these data quality issues within the specific context of menstrual cycle research, enabling more reproducible and robust analyses of cycle phase effects on various outcome measures.

Understanding Missing Data Mechanisms in Menstrual Cycle Research

Classification of Missing Data

In menstrual cycle studies, missing data can arise from various sources including participant non-compliance with daily symptom tracking, technical errors in hormone assay measurements, or skipped survey questions in electronic diaries. Understanding the mechanism behind missingness is crucial for selecting appropriate handling methods [57] [58].

Table 1: Types of Missing Data Mechanisms in Menstrual Cycle Research

Mechanism	Acronym	Definition	Menstrual Cycle Research Example
Missing Completely at Random	MCAR	Missingness unrelated to observed or unobserved data	A lab equipment malfunction randomly affects hormone assays regardless of participant characteristics [58]
Missing at Random	MAR	Missingness depends on observed but not unobserved data	Younger participants are more likely to skip income questions in a survey, with income missingness predictable by age [57]
Not Missing at Random	NMAR	Missingness depends on the unobserved value itself	Participants with very high premenstrual symptom scores avoid daily tracking, with missingness related to the unrecorded severe symptoms [58]

Implications for Menstrual Cycle Studies

The mechanism of missingness has direct implications for statistical validity in cycle research. Under MCAR, complete-case analysis remains unbiased though inefficient. For MAR data, multiple imputation techniques can recover unbiased estimates if the imputation model includes variables predictive of missingness. NMAR presents the greatest challenge, often requiring sensitivity analyses or specialized statistical models that explicitly account for the missingness mechanism [57] [58].

Protocol for Handling Missing Data

Detection and Visualization of Missing Data

Step 1: Quantify Missingness Patterns

• Calculate percentage of missing values for each variable of interest (hormone levels, symptom scores, physiological measures)
• Document timing of missingness relative to cycle phase (follicular, ovulatory, luteal)
• Identify patterns of missingness across participant subgroups (e.g., by PMDD status, age, or cycle regularity)

Step 2: Visualize Missing Data Structure

• Create missingness heatmaps to identify systematic patterns
• Use bar plots to display proportion of missing values per variable
• Generate scatterplot matrices with missingness indicators

R Code Implementation:

Imputation Techniques for Hormone and Symptom Data

Table 2: Imputation Methods for Menstrual Cycle Data

Method	Implementation	Use Case	Considerations for Cycle Research
Multiple Imputation by Chained Equations (mice)	mice(cycle_data, m=5, method='pmm')	Multivariate hormone data with mixed types [57] [58]	Include cycle day, phase, and participant characteristics in imputation model
Random Forest Imputation (missForest)	missForest(cycle_data)	Complex nonlinear relationships between hormones and symptoms [57]	Preserves interactions between hormones; robust to outliers
k-Nearest Neighbors Imputation	kNN(cycle_data, k=5)	Daily symptom patterns with temporal dependencies	Use cautiously with time-series structure of cycle data
Longitudinal Imputation	mice(cycle_data, method='2l.pan')	Repeated hormone measures across multiple cycles	Accounts for within-subject correlation across cycles

Step 3: Implement Multiple Imputation Protocol

Validation of Imputation Results

Step 4: Assess Imputation Quality

• Compare distributions of observed and imputed values using density plots
• Check consistency of imputed values with physiological ranges (e.g., progesterone levels in luteal phase)
• Verify preservation of covariance structure between hormones
• Conduct sensitivity analyses with different imputation methods

Protocol for Outlier Detection and Handling

Statistical Framework for Outlier Detection

Outliers in menstrual cycle research may represent true biological extremes (e.g., anovulatory cycles), measurement error (hormone assay interference), or data entry mistakes. Appropriate identification requires domain knowledge of physiological plausibility [59] [60].

Table 3: Outlier Detection Methods for Menstrual Cycle Data

Method	Threshold	Implementation	Application in Cycle Research
Z-score	±3 SD	abs(scale(value)) > 3	Identifying extreme hormone values beyond physiological range [60] [61]
Interquartile Range (IQR)	Q1 - 1.5×IQR, Q3 + 1.5×IQR	boxplot.stats(value)$out	Detecting anomalous symptom scores or cycle characteristics [60]
Local Outlier Factor (LOF)	Score > threshold	LocalOutlierFactor(n_neighbors=20)	Identifying unusual patterns in multivariate hormone profiles [61]
Isolation Forest	Anomaly score	IsolationForest(contamination=0.1)	Detecting anomalous cycles in high-dimensional data [59] [61]
Mahalanobis Distance	p < 0.001	mahalanobis(value, center, cov)	Multivariate outliers in hormone-symptom relationships [61]

Implementation of Outlier Detection

Step 1: Univariate Outlier Detection for Hormone Measures

Step 2: Multivariate Outlier Detection

Outlier Handling Strategies

Step 3: Treatment of Identified Outliers

Table 4: Outlier Handling Methods in Menstrual Cycle Research

Method	Implementation	Use Case	Considerations
Trimming	filter(!index %in% outliers)	Clear measurement errors or data entry mistakes [60]	Risk of losing rare but biologically meaningful events
Winsorization	pmin(pmax(value, lower), upper)	Extreme but plausible hormone values [59]	Preserves sample size while reducing extreme value influence
Imputation	ifelse(outlier, median(value, na.rm=TRUE), value)	Questionable values with partial information [60]	Median preferred over mean for skewed hormone distributions
Transformation	log(value + 1)	Skewed hormone distributions [59]	Improves normality but complicates interpretation
Robust Analysis	rlm(response ~ predictors)	Data with multiple minor outliers	Uses models less sensitive to outliers

Integrated Workflow for Data Quality Control

Comprehensive Data Cleaning Pipeline

The following workflow integrates missing data and outlier handling specifically for menstrual cycle research:

Quality Assurance and Documentation

Step 1: Pre-Cleaning Documentation

• Record original data dimensions and missingness percentages
• Document all identified outliers with rationale for classification
• Maintain version control for all data cleaning steps

Step 2: Post-Cleaning Validation

• Verify physiological plausibility of cleaned data (e.g., progesterone levels by cycle phase)
• Confirm preservation of expected correlations between hormones
• Ensure no systematic bias introduced by cleaning procedures

Step 3: Reporting Standards

• Transparent documentation of all data handling decisions
• Sensitivity analyses comparing results with different handling approaches
• Complete reproducible code for all preprocessing steps

Research Reagent Solutions

Table 5: Essential Computational Tools for Menstrual Cycle Data Quality Control

Tool Name	Function	Application in Cycle Research	Implementation
mice R Package	Multiple Imputation	Handling missing hormone data and symptom scores [57] [58]	mice(cycle_data, m=5, method='pmm')
missForest R Package	Random Forest Imputation	Nonparametric imputation for complex hormone relationships [57]	missForest(cycle_data)
naniar R Package	Missing Data Visualization	Exploring patterns of missingness in daily diary data [58]	gg_miss_var(cycle_data)
Isolation Forest	Anomaly Detection	Identifying anomalous cycles in multivariate time-series data [61]	IsolationForest(contamination=0.1)
Local Outlier Factor	Density-Based Outlier Detection	Detecting unusual symptom patterns relative to cycle phase [61]	LocalOutlierFactor(n_neighbors=20)
Carolina Premenstrual Assessment Scoring System (C-PASS)	Cycle Phase and PMDD Diagnosis	Standardized scoring of daily symptoms for phase determination and outlier identification [1]	Available at www.cycledx.com

Robust handling of missing data and outliers is particularly crucial in menstrual cycle research where biological variability, complex hormone interactions, and participant compliance challenges create unique data quality considerations. The protocols outlined herein provide a standardized approach for ensuring data integrity while maintaining physiological validity. By implementing these comprehensive methodologies, researchers can enhance the reproducibility and reliability of findings in studies examining menstrual cycle associations across physiological, behavioral, and clinical domains.

In scientific research, particularly in fields like menstrual cycle associations research, the clear presentation of complex, multi-dimensional data is paramount. Chartjunk refers to all visual elements in charts and figures that are not necessary to comprehend the information presented or that distract the viewer from this information [62]. This includes excessive gridlines, ornamental shading, redundant labels, and decorative graphics that do not convey data. The concept, coined by Edward Tufte, emphasizes maximizing the data-ink ratio—the proportion of ink (or pixels) dedicated to displaying the actual data versus non-data or redundant elements [63] [64]. For researchers, scientists, and drug development professionals, avoiding chartjunk is not merely an aesthetic preference but a fundamental practice to ensure data is communicated accurately, efficiently, and without misinterpretation.

The stakes are high in menstrual cycle research, where data often involves tracking numerous subjects across multiple cycles, incorporating variables such as hormone levels, physiological symptoms, and behavioral metrics. Cluttered visualizations can obscure significant patterns, such as the relationship between ovarian hormone fluctuations and symptom severity, potentially leading to flawed interpretations. Adhering to principles of clarity and precision in data visualization is therefore critical for producing valid, reproducible, and impactful scientific findings.

Foundational Principles for Avoiding Chartjunk

Maximize the Data-Ink Ratio

The core idea is that the majority of ink on a graphic should represent data. To achieve this:

• Remove heavy gridlines and borders: Use faint gray lines for gridlines if they are necessary, or remove them entirely if data points are clearly labeled [64].
• Eliminate background shading and 3D effects: These decorative elements distort perception and add no informational value. Stick to clean, two-dimensional representations [65] [64].
• Avoid redundant data labels: Ensure every label provides new information. For instance, if a chart title is "Serum Estradiol Levels Across the Menstrual Cycle," the y-axis need only be labeled "Estradiol (pg/mL)" without redundant context [64].

Use Color with Strategic Purpose

Color should be used functionally to encode information or draw attention, not decoratively.

• Limit the color palette: Use a neutral color (e.g., gray) for the majority of data points and a highlight color to draw attention to key findings or specific subject groups [65] [64].
• Ensure accessibility: Choose color palettes that are distinguishable for individuals with color vision deficiencies. Tools like ColorBrewer can help select accessible schemes. Always avoid problematic combinations like red-green to convey critical contrasts [64].
• Leverage color meaning: In menstrual cycle research, using consistent colors for specific phases (e.g., blue for follicular, red for luteal) across all figures can speed up comprehension [66].

Implement Direct Labeling

Eliminate the cognitive load of cross-referencing a legend by labeling data series directly on the visualization.

• Place labels proximate to data lines or bars: This allows the audience to quickly identify each data series without looking back and forth to a separate key [63].
• Replace text with images where effective: In some cases, Tufte suggests replacing text labels with intuitive images. For instance, a chart comparing different subject groups could use small, simple icons instead of words, allowing for quicker pattern recognition [63].

Data Organization and Standardization Protocol

Menstrual Cycle Phase Definitions

Standardizing the operational definition of menstrual cycle phases is a critical first step in organizing data for clear visualization. The following table outlines a consensus approach based on hormonal profiles and ovulation timing [1].

Table 1: Standardized Definitions for Menstrual Cycle Phases

Phase Name	Operational Definition	Key Hormonal Profile
Menstrual Phase	Days 1-5 of the cycle, starting with the first day of menstrual bleeding.	Low and stable estradiol (E2) and progesterone (P4).
Mid-Follicular Phase	Approximately days 6-8, but best defined by hormone levels.	Low and stable E2 and P4.
Late Follicular/Periovulatory Phase	The 3 days surrounding ovulation (including the day before, day of, and day after).	Characterized by a peak in E2 and a surge in Luteinizing Hormone (LH).
Mid-Luteal Phase	Approximately 6-8 days after ovulation.	Characterized by peaking P4 and a secondary peak in E2.
Late Luteal/Perimenstrual Phase	The 3 days preceding the next menstrual onset.	Characterized by a rapid withdrawal of E2 and P4.

Quantitative Data on Cycle Variability

Understanding population-level variability is essential for designing studies and interpreting multi-cycle data. The following table summarizes real-world data from a large-scale study of over 600,000 cycles, providing a reference for expected ranges [67].

Table 2: Real-World Menstrual Cycle Characteristics (n=612,613 cycles)

Parameter	Mean Duration (Days)	95% Confidence Interval (Days)	Notes
Overall Cycle Length	29.3	~21 - 37	Mean length decreases by 0.18 days per year of age from 25-45.
Follicular Phase Length	16.9	10 - 30	Accounts for most variance in total cycle length. Decreases with age.
Luteal Phase Length	12.4	7 - 17	More consistent in length than the follicular phase. Shows little variation with age.
Bleed Length	~4.0	Not specified	Reduces slightly with age.

Visualization Workflows for Multi-Dimensional Data

Visualizing data that spans multiple subjects and cycles requires methods to handle high dimensionality. The following workflow diagrams outline proven strategies.

Data Visualization Selection Workflow

This diagram provides a logical pathway for selecting the most appropriate and clear visualization based on the research question and data structure.

Multi-Subject Multi-Cycle Data Visualization Strategy

This diagram illustrates a systematic approach to handling and visualizing complex datasets involving numerous subjects and cycles.

The Scientist's Toolkit: Research Reagent Solutions

A standardized set of tools and reagents is crucial for collecting the high-quality data necessary for clear visualization. The following table details essential items for rigorous menstrual cycle research.

Table 3: Essential Research Reagents and Materials for Menstrual Cycle Studies

Item	Function/Application	Protocol Notes
Urinary Luteinizing Hormone (LH) Test Kits	At-home detection of the LH surge to pinpoint ovulation with high temporal resolution [67].	Critical for defining the periovulatory phase and aligning cycles by ovulation date rather than by menstrual onset alone.
Basal Body Temperature (BBT) Thermometers	Tracking the slight rise in resting body temperature that occurs after ovulation due to progesterone [67].	Provides a cheap, longitudinal measure for confirming ovulation and estimating luteal phase length. Digital thermometers with high precision are recommended.
Saliva or Serum Hormone Assays	Quantifying absolute levels of estradiol (E2) and progesterone (P4) for phase confirmation and dynamic modeling [1].	Enzyme-linked immunosorbent assays (ELISAs) are standard. Serum provides more accurate absolute levels, while saliva allows for easier, more frequent sampling.
Validated Daily Symptom Diaries	Prospective, daily monitoring of emotional, cognitive, and physical symptoms to link with cycle phase [1].	Retrospective recall is highly unreliable. The Carolina Premenstrual Assessment Scoring System (C-PASS) is a standardized tool for diagnosing PMDD and PME.
Data Visualization Software (e.g., Python/pandas/matplotlib, R/ggplot2)	Creating reproducible, customizable scientific visualizations free from the default chartjunk often found in basic spreadsheet software [68].	Allows for precise control over all chart elements (data-ink ratio, color, labels) to implement best practices programmatically.

Benchmarking New Methods: Validating ML and Wearable-Driven Insights

Within menstrual cycle research and drug development, the accurate measurement of hormonal fluctuations is paramount. The gold standard for confirming ovulation and defining cycle phases relies on precise hormonal assessment, typically involving transvaginal ultrasound and serum hormone testing [50]. However, the need for less invasive, more feasible methods for field settings or frequent monitoring has spurred the development and use of urinary luteinizing hormone (LH) tests and other salivary and urinary assays [50] [69]. This document outlines the critical protocols for validating these alternative methods against gold-standard serum measures, framed within the broader context of data visualization techniques for menstrual cycle associations research. Ensuring the validity and precision of urinary and salivary hormone detection methods is a fundamental prerequisite for generating reliable, actionable data in both clinical and research environments [50] [28].

The following tables consolidate key quantitative findings from recent validation studies, providing a clear comparison of methodological performance and hormonal thresholds.

Table 1: Agreement in Ovulation Day Detection between Urinary Hormone Monitors

Comparison	Participant Group	Cycles (n)	Correlation (R)	Agreement (±1 day)	Primary Citation
Mira vs. ClearBlue Fertility Monitor (CBFM)	Postpartum (after first menses)	18	0.94	71%	[69]
Mira vs. ClearBlue Fertility Monitor (CBFM)	Perimenopause	35	0.83	82%	[69]
Mira vs. ClearBlue Fertility Monitor (CBFM)	Regular Cycles	57	0.98	95%	[69]

Table 2: Key Hormone Thresholds and Ranges in Validation Studies

Hormone / Metric	Matrix	Reported Threshold or Range	Context	Primary Citation
LH Surge (for ovulation)	Urine (Mira)	> 11 mIU/mL	Threshold for surge identification	[69]
LH Level (pre-progesterone)	Serum (FET cycles)	Quartiles: ≤6.41, 6.41-17.14, >17.14 mIU/mL	Association with live birth rate	[70]
PDG Threshold (luteal phase entry)	Urine	5 μg/mL	Defines start of infertile luteal phase	[71]
Basal Body Temperature (BBT) Shift	-	> 0.2 - 0.5 °C sustained increase	Confirms ovulation post-hoc	[28]

Experimental Protocols

Protocol for Validating a Urinary LH Assay Against Serum LH

Objective: To determine the concordance between the day of the urinary LH surge detected by a commercial fertility monitor (e.g., Mira) and the serum LH peak, considered a gold-standard marker for impending ovulation [69] [71].

Materials:

• Participants: Naturally cycling, premenopausal women.
• Test Device: Quantitative urinary hormone monitor (e.g., Mira monitor) and corresponding test wands.
• Gold Standard: Access to phlebotomy for daily serum sampling.
• Laboratory: Capable of performing serum LH immunoassays.
• Additional Measures: Menstrual diary for cycle day tracking.

Procedure:

• Participant Recruitment & Screening: Recruit eligible participants with regular menstrual cycles (21-35 days). Exclude individuals on hormonal contraception or with conditions known to affect ovulation (e.g., PCOS) [69] [72].
• Study Initiation: Instruct participants to begin daily first-morning urine testing with the monitor from the end of menses (approximately cycle day 5-7) until the monitor confirms an LH surge or menstruation begins.
• Serum Sampling: Schedule daily blood draws at a clinical facility, starting on the same day as urinary testing. Continue until an LH surge is detected in urine or for the duration of the cycle.
• Hormone Analysis:
  • Urine: Follow manufacturer instructions for the quantitative monitor. Record the numerical LH values and the device-designated surge day [69].
  • Serum: Analyze serum samples for LH using a validated immunoassay (e.g., Abbott Architect ci4100) in a CAP/CLIA-certified laboratory [71].
• Data Alignment and Analysis:
  • Index both urinary and serum hormone data to the day of the serum LH peak (defined as the highest concentration, designated Day 0).
  • Compare the day of the urinary LH peak (highest value over a predefined threshold, e.g., 11 mIU/mL) to Day 0.
  • Use statistical methods like Pearson's correlation or Bland-Altman analysis to assess the agreement between the two methods for identifying the LH surge day [69].

Protocol for Correlating Urinary Hormone Metabolites with Serum Estradiol and Progesterone

Objective: To assess the relationship between urinary estrone-3-glucuronide (E3G) and pregnanediol-3-glucuronide (PDG) and their serum counterparts, estradiol (E2) and progesterone (P), across the menstrual cycle [71].

Materials:

• Participants: As in Protocol 3.1.
• Test Device: Fertility monitor capable of quantifying E3G and PDG (e.g., Mira).
• Gold Standards: Phlebotomy for serum; transvaginal ultrasonography (TVUS) for follicle tracking.
• Laboratory: For serum E2 and P immunoassays.

Procedure:

• Study Setup: Recruit participants as above. Obtain daily first-morning urine samples and concurrent daily blood samples throughout one complete menstrual cycle.
• Ovulation Confirmation: Perform daily or near-daily TVUS starting in the mid-follicular phase to track dominant follicle growth and collapse. Define the day of follicle collapse as Day 0 [71].
• Hormone Analysis:
  • Urine: Analyze daily urine samples for E3G and PDG using the quantitative monitor.
  • Serum: Analyze daily serum samples for E2 and P.
• Data Synthesis and Validation:
  • Align all hormone data (serum and urine) to the TVUS-defined Day 0.
  • Visually inspect and statistically correlate (e.g., using cross-correlation analysis) the trajectories of urinary E3G with serum E2, and urinary PDG with serum P.
  • Test the ability of urinary PDG thresholds (e.g., 5 μg/mL) to accurately identify the luteal phase transition, as confirmed by serum progesterone rise and TVUS [71].

The following diagram illustrates the core workflow for validating urinary hormone tests against serum standards.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Materials for Hormone Validation Studies

Item	Function/Description	Example Use Case
Quantitative Urinary Hormone Monitor (e.g., Mira, Inito)	Measures concentration of LH, E3G, and PDG in first-morning urine via fluorescent or optical assays.	At-home daily tracking by participants to detect fertile window and ovulation [69] [71].
Qualitative Urinary LH Test Kits (e.g., ClearBlue)	Detects LH surge above a threshold, providing "Low," "High," or "Peak" readings.	Used as a comparator in validation studies against quantitative monitors [69] [72].
Serum Hormone Immunoassays	Quantifies precise levels of LH, estradiol (E2), and progesterone (P) in blood serum.	Gold-standard reference method for validating the accuracy of urinary hormone tests [50] [71].
Transvaginal Ultrasound (TVUS)	Visualizes ovarian follicles to directly observe growth and collapse, confirming ovulation.	Provides the definitive gold-standard timeline for aligning hormonal events [71].
Menstrual Cycle Tracking Software/App	Logs cycle start dates, symptoms, and urinary hormone data for visualization and analysis.	Enables prospective data collection and preliminary cycle phase identification [28] [73].

Data Visualization and Analysis Pathways

Effective data visualization is critical for interpreting the complex, longitudinal data generated in menstrual cycle research. The following diagram outlines a standardized pathway for processing and visualizing hormone data to identify key cycle events.

Key Visualization Techniques:

• Spaghetti Plots: Individually plot hormone levels for each participant across the cycle to visualize within-person changes and inter-individual variability [28] [1].
• Person-Centering: Subtract an individual's mean hormone level across their cycle from each daily value to better visualize cyclic change relative to their own baseline [28].
• Algorithmic Analysis: Employ mathematical tools like the Fertility Indicator Equation (FIE) with estradiol data to signal the start of the 6-day fertile window, or Area Under the Curve (AUC) algorithms with estradiol and progesterone to identify the ovulation/luteal transition [71].

Comparing Traditional Basal Body Temperature (BBT) with Newer Digital Biomarkers

The accurate classification of menstrual cycle phases and detection of ovulation is critical for women's health management, particularly in addressing infertility, alleviating premenstrual syndrome, and preventing hormone-related disorders [13]. For decades, basal body temperature (BBT) tracking has served as a fundamental fertility awareness method (FAM), relying on the physiological biphasic temperature shift driven by progesterone following ovulation [74] [75]. The emergence of digital biomarkers—defined as objective, quantifiable, physiological, and behavioral measures collected by portable, wearable, implantable, or digestible digital devices [76]—is transforming this field. This Application Note provides a structured comparison and detailed protocols for employing traditional BBT and newer digital biomarkers in menstrual cycle research, framed within the context of data visualization techniques for menstrual cycle associations.

The table below summarizes the core characteristics of traditional BBT and digital biomarkers, highlighting key operational and methodological differences.

Table 1: Comparison of Traditional BBT and Digital Biomarkers for Menstrual Cycle Research

Parameter	Traditional BBT	Digital Biomarkers
Definition	Measurement of core body temperature at rest, typically oral/rectal/vaginal, upon waking [74].	Objective, quantifiable physiological/behavioral data from wearable, portable devices [76].
Primary Biomarker	Single, daily basal body temperature reading.	Continuous, longitudinal data streams (e.g., wrist skin temperature, circadian heart rate) [76] [74] [13].
Data Granularity	Single data point per day ("snapshot") [76].	High-frequency, continuous data collected passively during sleep or daily living [76] [74] [13].
Key Advantages	Low start-up cost, well-documented in literature, teaches body awareness [74].	Passive, automatic data capture reducing user burden; higher granularity and robustness to lifestyle factors; enables advanced analytics/Machine Learning [74] [13].
Key Limitations	Susceptible to environmental factors, sleep timing, and user error; inconvenient for some; only confirms ovulation after it has occurred [74] [13].	Higher initial cost; data complexity requiring specialized analytics; newer field with evolving regulatory guidance [76] [74].
Vulnerability to Confounders	High (e.g., alcohol, late sleep, travel) [74].	Low (e.g., impervious to lifestyle factors like alcohol, sex, eating late) [74].

Quantitative Data Comparison

The following table consolidates key performance data from published studies on traditional and digital biomarkers, providing a basis for empirical comparison.

Table 2: Summary of Quantitative Performance Data from Selected Studies

Methodology	Study Details	Key Performance Findings
Traditional BBT	Established method based on the "three-over-six" rule [74].	BBT nadir aligns with ovulation day in only ~43% of cycles [74]. A sustained 3-day temperature shift was observed in 82% of cycles using a digital method [74].
Wrist Skin Temperature (WST)	136 women, 437 cycles; WST measured with wearable biosensors during sleep [74].	The average early-luteal phase WST was 0.33°C higher than in the fertile window. WST changes were impervious to lifestyle factors that confound BBT [74].
Machine Learning & minHR	40 healthy women; model using heart rate at circadian rhythm nadir (minHR) under free-living conditions [13].	Adding minHR significantly improved luteal phase classification and ovulation prediction. In participants with high sleep timing variability, the minHR-model reduced absolute errors in ovulation detection by 2 days compared to a BBT-based model [13].

Detailed Experimental Protocols

Protocol for Traditional BBT Tracking and Analysis

This protocol outlines the standardized procedure for collecting and interpreting BBT data in a research setting.

A. Materials and Equipment

• High-Sensitivity Digital Thermometer: Accurate to 0.01°C or 0.1°F for detecting subtle shifts [74].
• Data Recording Tool: Paper chart or digital app designed for BBT charting.
• Participant Instruction Sheet.

B. Procedure

• Measurement Timing: Immediately upon waking, before any physical activity, including sitting up or talking [74].
• Consistency: Temperature should be taken at approximately the same time every morning, as variances in waking time can introduce noise due to circadian rhythms [74].
• Method: Place the thermometer orally, rectally, or vaginally as consistent throughout the cycle. The rectal and vaginal routes are considered more reliable.
• Recording: Record the temperature immediately on the chart or app. Participants should also note confounding factors (e.g., poor sleep, alcohol, illness, travel) [74].

C. Data Analysis and Interpretation

• Plotting: Create a daily temperature curve over the menstrual cycle.
• Identifying the Biphasic Pattern: Visually identify the biphasic shift. The "three-over-six" rule is a common analytical method: an upward trend is confirmed when three consecutive daily readings are higher than the six preceding temperatures [74].
• Identifying Ovulation: The day of ovulation is typically identified as the last day of the lower temperature plateau or the day before the sustained temperature rise [74]. This is a retrospective confirmation.

Protocol for Digital Wrist Skin Temperature (WST) Tracking

This protocol describes the methodology for using wearable sensors to capture WST as a digital biomarker.

A. Materials and Equipment

• Wearable WST Biosensor: A validated, research-grade device capable of continuously measuring skin temperature at the wrist (e.g., sampling every few minutes during sleep) [74].
• Paired Software Platform: For data aggregation, visualization, and analysis.

B. Procedure

• Sensor Placement: Participants wear the biosensor on the wrist during sleep.
• Data Capture: The device passively and continuously records WST throughout the night.
• Data Synchronization: Participants regularly sync the device with its companion application to upload data.
• Ancillary Data: Participants may report daily activities or cycle events (e.g., menses) via the app [74].

C. Data Analysis and Interpretation

• Data Processing: The software algorithm processes the raw, high-density WST data to generate a nightly summary statistic (e.g., mean nightly WST).
• Cycle Phase Detection: The algorithm identifies the characteristic biphasic pattern. The fertile window and ovulation are estimated based on the WST nadir and subsequent sustained shift [74]. The analysis is automated, reducing interpreter bias.

The workflow for implementing these methodologies in a research context is illustrated below.

The Scientist's Toolkit: Research Reagent Solutions

The following table details essential materials and tools required for conducting research in this domain.

Table 3: Essential Research Reagents and Materials

Item	Function/Application	Examples & Notes
High-Precision BBT Thermometer	Measures subtle (0.01°C) temperature changes for traditional BBT tracking.	Clinical-grade digital thermometers for oral/rectal use.
Wearable Biosensors	Passively and continuously captures physiological data (e.g., temperature, heart rate) under free-living conditions.	Wrist-worn devices (e.g., Empatica, Garmin) or chest straps validated for research.
Luteinizing Hormone (LH) Test Kits	Provides a biochemical gold standard for confirming ovulation timing in research protocols.	Urinary test strips (e.g., Wondfo) or digital readers (e.g., ClearBlue).
Data Visualization & Analysis Software	For statistical modeling, generating spaghetti plots, and analyzing longitudinal within-person cycles.	R, Python, SAS with specialized packages for longitudinal data and mixed models [1].
Fertility Awareness Charting App	Allows for standardized digital recording of BBT and other biomarkers (cervical mucus) by participants.	Apps based on evidence-based Fertility Awareness Methods (FABMs) [75].
Machine Learning Framework	To develop predictive models for ovulation and cycle phase classification from complex digital biomarker data.	XGBoost, Scikit-learn [13].

Data Visualization in Menstrual Cycle Research

The menstrual cycle is a within-person process and should be treated as such in experimental design and statistical modeling [1]. Repeated measures are the gold standard. Effective data visualization is critical for exploring and presenting this longitudinal data:

• Spaghetti Plots: Graph outcomes for each participant individually across the cycle to visualize within-person change and between-person differences in patterns [1].
• Person-Centering: Subtract an individual's mean across all observations from each of their data points before group-level graphing. This helps isolate within-person cycle effects from stable between-person trait differences [1].

The relationship between data collection, analysis, and the underlying endocrinology can be visualized as a pathway diagram.

Evaluating Machine Learning Model Performance for Phase Classification

Accurate classification of menstrual cycle phases is critical for advancing women's health research, with applications in infertility, premenstrual syndrome, and hormone-related disorder management [13]. Traditional methods like basal body temperature (BBT) tracking are susceptible to disruptions in sleep timing and environmental conditions, limiting their practical application in large-scale studies and clinical trials [13] [77]. Recent advances in wearable sensor technology and machine learning (ML) have enabled more robust, continuous monitoring under free-living conditions, offering new opportunities for non-invasive cycle phase classification and ovulation prediction. This protocol evaluates the performance of contemporary ML models for menstrual phase identification, providing researchers and drug development professionals with standardized methodologies for validating classification approaches within the broader context of data visualization techniques for menstrual cycle associations research.

The following table summarizes quantitative performance metrics from recent studies applying machine learning to menstrual cycle phase classification, providing a benchmark for model evaluation.

Table 1: Performance Metrics of Machine Learning Models for Menstrual Cycle Phase Classification

Study Reference	Model Type	Input Features	Classification Task	Accuracy	AUC-ROC	Key Performance Notes
minHR Study [13] [77]	XGBoost	Circadian rhythm nadir heart rate (minHR)	Luteal phase classification & ovulation day detection	-	-	Significantly improved luteal phase recall; Reduced ovulation detection absolute errors by 2 days in high sleep variability participants
Multi-Parameter Wristband [11]	Random Forest (Fixed Window)	HR, IBI, EDA, Skin Temperature	3 phases (Period, Ovulation, Luteal)	87%	0.96	Best performance with non-overlapping fixed-size windows
Multi-Parameter Wristband [11]	Random Forest (Sliding Window)	HR, IBI, EDA, Skin Temperature	4 phases (Period, Follicular, Ovulation, Luteal)	68%	0.77	Daily phase tracking using sliding window approach
In-Ear Sensor [11]	Hidden Markov Model	Continuous temperature (5-min intervals during sleep)	Ovulation occurrence	76.92%	-	Correctly identified ovulation in 30/39 cycles
ECG-Based [11]	Radial Basis Function (RBF) Network	HRV Features	3 phases (Follicular, Ovulation, Luteal)	95%	-	Using 6-minute ECG signals from 14 women
Wrist Temperature & HR [11]	Machine Learning (Unspecified)	Wrist temperature, heart rate	Fertile window prediction	87.46% (regular cycles), 72.51% (irregular cycles)	-	Data from over 100 women using ear thermometer and Huawei Band 5

Experimental Protocols

minHR-Based Model Development (XGBoost)

Objective

Develop a machine learning model using circadian rhythm-based heart rate features to classify menstrual cycle phases and predict ovulation day, with particular robustness to variability in sleep timing [13] [77].

Participant Selection and Data Collection

• Cohort: 40 healthy women aged 18-34 years
• Study Duration: Maximum of three menstrual cycles per participant
• Conditions: Data collected under free-living conditions to enhance practicality and real-world applicability
• Stratification: Participants stratified into groups based on high variability versus low variability in sleep timing

Feature Engineering

• Primary Feature: Heart rate at the circadian rhythm nadir (minHR) extracted from sleeping heart rate data
• Comparison Features:
  • "day": Number of days elapsed since onset of menstruation
  • "day + BBT": Combination of day count and basal body temperature
• Feature Combinations Evaluated: "day", "day + minHR", and "day + BBT"

Model Training and Validation

• Algorithm: XGBoost
• Validation Method: Nested leave-one-group-out cross-validation
• Performance Assessment:
  • Luteal phase classification performance (recall)
  • Ovulation day detection absolute errors
  • Statistical significance testing (p < 0.05)

Multi-Parameter Wristband Model (Random Forest)

Objective

Develop classification models using multiple physiological signals from wrist-worn devices to identify menstrual cycle phases without participant input [11].

Participant Selection and Data Collection

• Cohort: 22 participants initially, with 18 included in final analysis (65 ovulatory cycles)
• Exclusion Criteria: Absence of positive LH test (3 participants, 8 cycles), missing data (1 participant, 2 cycles)
• Devices: E4 and EmbracePlus wristbands
• Duration: 2 to 5 months of continuous monitoring
• Physiological Signals: Heart rate (HR), interbeat interval (IBI), electrodermal activity (EDA), skin temperature, accelerometry (ACC)

Phase Definition and Labeling

• Menses (P): Beginning of cycle characterized by menstrual bleeding
• Follicular (F): Following menses, ends before LH surge
• Ovulation (O): Period spanning 2 days before to 3 days after positive LH test
• Luteal (L): After ovulation, corpus luteum produces progesterone

Feature Extraction Approaches

• Fixed Window Technique: Features extracted from non-overlapping fixed-size windows
• Rolling Window Technique: Features extracted using sliding windows for daily phase tracking

Model Training and Validation

• Algorithms: Random Forest, Logistic Regression, and others
• Validation Approaches:
  • Leave-last-cycle-out: Data from initial 47 cycles for training, last 18 cycles from 18 subjects for testing
  • Leave-one-subject-out: Data from all but one subject for training, remaining subject's data for testing
• Performance Metrics: Accuracy, precision, recall, F1-score, AUC-ROC

Performance Data Tables

Table 2: Detailed Model Performance Across Validation Approaches

Model & Conditions	Phases Classified	Validation Method	Accuracy	Precision	Recall	F1-Score	AUC-ROC
Random Forest (Fixed Window) [11]	3 (P, O, L)	Leave-last-cycle-out	87%	87%	87%	87%	0.96
Random Forest (Fixed Window) [11]	3 (P, O, L)	Leave-one-subject-out	87%	-	-	-	-
Random Forest (Sliding Window) [11]	4 (P, F, O, L)	Leave-last-cycle-out	68%	-	-	-	0.77
Logistic Regression (Fixed Window) [11]	4 (P, F, O, L)	Leave-one-subject-out	63%	-	-	-	-

Table 3: Comparative Performance of Feature Sets in minHR Study

Feature Set	Luteal Phase Recall	Ovulation Detection Error	Notes
day only [13]	Baseline	Baseline	Reference for comparison
day + minHR [13]	Significant improvement	2-day reduction in absolute error	Particularly effective in high sleep variability participants
day + BBT [13]	Less improvement than minHR	Higher error than minHR	Susceptible to sleep timing disruptions

Research Reagent Solutions

Table 4: Essential Research Materials and Tools for Menstrual Cycle Phase Classification Studies

Research Reagent	Function/Application	Example Implementation
Wrist-worn Physiological Monitors	Continuous data collection of HR, IBI, EDA, skin temperature	E4 and EmbracePlus wristbands [11]
Basal Body Temperature (BBT) Sensors	Traditional ovulation confirmation through temperature shifts	OvuSense vaginal temperature sensor [11]
Urinary Luteinizing Hormone (LH) Tests	Gold standard for ovulation detection and phase labeling	At-home LH test kits for determining ovulation phase [11]
In-Ear Temperature Sensors	Continuous core body temperature monitoring during sleep	Sensor measuring temperature every 5 minutes during sleep [11]
ECG Signal Acquisition Systems	Recording cardiac signals for heart rate variability analysis	6-minute ECG recordings for HRV feature extraction [11]
Data Visualization Palettes	Accessible color schemes for data representation	Carbon Design System categorical palette with 3:1 contrast ratio [78]

Experimental Workflow and Signaling Pathways

Menstrual Cycle Phase Classification Workflow

Physiological Signaling Pathways in Menstrual Cycle Tracking

Model Validation Methodology

Ethical Considerations in Algorithm-Driven Tracking and Visualization

Application Notes: Core Ethical Principles and Implementation

Algorithm-driven tracking and visualization in menstrual cycle research present unique ethical challenges concerning data privacy, algorithmic fairness, and the accurate communication of intimate health data. Adherence to the following core principles is critical for maintaining scientific integrity and participant trust.

1.1 Foundational Ethical Principles

• Transparency: Clearly document all data sources, algorithmic processes, and visualization methodologies. This includes disclosing the limitations of tracking models and any potential uncertainties in phase prediction or data interpretation [79] [80].
• Fairness and Equity: Proactively identify and mitigate biases in training data and algorithms that could lead to inequitable outcomes for diverse demographic groups, including variations in cycle patterns across different populations [80].
• Privacy and Confidentiality: Implement robust data protection measures. Menstrual cycle data is highly sensitive personal health information; it must be anonymized and secured to prevent unauthorized access or breaches [80].
• Accuracy in Representation: Ensure all visualizations and reports accurately reflect the underlying data. Avoid manipulating scales, omitting outliers, or using visual techniques that could mislead or exaggerate findings [79] [81].

1.2 Ethical Data Presentation Protocol

The following table summarizes the primary ethical risks in data presentation and their corresponding mitigation strategies for research communication.

Table 1: Ethical Data Presentation Framework for Research Communication

Ethical Risk	Description	Mitigation Strategy
Scale Manipulation [81]	Using truncated or non-zero-based axes to exaggerate minor differences.	Use axes that start at zero where appropriate and maintain consistent, proportionate scales [79].
Omission of Data	Removing outliers or inconvenient data points that do not fit a desired narrative.	Present a complete picture of the data; include and annotate all relevant data points [79].
Color Bias [81]	Using color in a way that misdirects attention or misrepresents relationships.	Use color purposefully to highlight, not deceive. Ensure palettes are accessible to those with color vision deficiencies [81].
Lack of Context	Presenting data without sufficient background, leading to misinterpretation.	Provide comprehensive context, including sample sizes, methodologies, and explanations of unavoidable biases [79].

Experimental Protocols: Algorithmic Tracking and Visualization

2.1 Protocol: Development of an Ethical Tracking Model

This protocol outlines the steps for building a machine learning model for menstrual cycle phase classification, based on a study that used circadian rhythm-based heart rate [13].

Aim: To develop a robust model for classifying menstrual cycle phases (e.g., follicular, luteal) and predicting ovulation using physiological data collected under free-living conditions.

Materials & Methods:

• Participants: Recruit a cohort of healthy women (e.g., 40 participants, aged 18-34), stratifying for factors like variability in sleep timing [13].
• Data Collection:
  • Primary Feature: Heart rate at the circadian rhythm nadir (minHR) [13].
  • Comparative Feature: Basal Body Temperature (BBT) [13].
  • Contextual Data: Cycle day count since menstruation onset [13].
• Machine Learning: Utilize a model such as XGBoost. Evaluate feature combinations (e.g., "day", "day + minHR", "day + BBT") using nested cross-validation (e.g., leave-one-group-out) to assess performance robustly [13].
• Performance Metrics: Assess model performance using metrics like recall for luteal phase classification and the absolute error (in days) for ovulation day detection [13].

Ethical Considerations:

• Obtain informed consent that explicitly details data usage for algorithm training [80].
• Implement data minimization by collecting only essential physiological signals [80].
• Plan for continuous monitoring of model performance to identify and correct for concept drift or emerging biases [80].

2.2 Workflow Visualization: Ethical Tracking Model Pipeline

The following diagram illustrates the integrated stages of data collection, model development, and ethical governance as described in the protocol.

Diagram 1: Ethical tracking model development workflow.

2.3 Protocol: Ethical Data Visualization and Reporting

Aim: To create data visualizations that are accurate, accessible, and resist misinterpretation for reporting findings in scientific publications and to stakeholders.

Methods:

• Chart Selection: Choose the graph type that best represents the data without distorting the message. For comparing proportions, bar charts are often more accurate than pie charts for discerning fine distinctions [82].
• Axis and Scale Integrity:
  • Ensure scales on all axes are consistent and proportionate [79].
  • For bar charts and histograms, the frequency axis should start at zero to avoid visual misrepresentation [83].
• Color and Accessibility:
  • Use color to enhance comprehension, not as the sole source of information.
  • Ensure sufficient color contrast between foreground elements (text, symbols) and their background. For standard text, a minimum contrast ratio of 4.5:1 is recommended, and 7:1 for higher compliance [84].
  • Verify that visualizations are interpretable for individuals with color vision deficiencies.
• Complete Representation:
  • Present all data in a complete context, avoiding masking or omitting portions of graphs [79].
  • Clearly represent uncertainty or variability in the data, such as confidence intervals or error bars [81].
• Attribution and Labeling:
  • Provide clear, descriptive titles and labels for all charts and tables [79] [82].
  • Acknowledge all third-party data sources appropriately [79].

The Scientist's Toolkit: Research Reagent Solutions

Table 2: Essential Materials and Computational Tools for Algorithm-Driven Tracking Research

Item / Tool	Function / Description	Ethical Consideration
XGBoost Algorithm [13]	A machine learning model used for classifying menstrual cycle phases based on input features like minHR and BBT.	Requires auditing for fairness to ensure it does not perpetuate biases present in training data [80].
Circadian Heart Rate (minHR) [13]	A novel physiological feature; heart rate at the lowest point of the circadian rhythm, used to improve luteal phase classification.	Collection of continuous physiological data demands high standards of privacy and informed consent [80].
Basal Body Temperature (BBT) [13]	A traditional metric for cycle tracking; used as a comparative feature against minHR.	Susceptible to confounding factors (e.g., sleep disruption); its limitations must be transparently communicated [13].
Nested Cross-Validation [13]	A robust model validation technique used to provide a realistic estimate of model performance on unseen data.	Promotes transparency and accountability by preventing over-optimistic performance reports [79].
Color Contrast Analyzer	A software tool to verify that visualizations meet minimum contrast ratios (e.g., WCAG guidelines).	Ensures accessibility and inclusivity, making research findings available to a wider audience [84] [81].

3.1 Visualization: Ethical Framework for Algorithmic Research

The following diagram maps the key ethical principles that should govern the entire research lifecycle, from data collection to dissemination.

Diagram 2: Ethical framework for algorithmic research lifecycle.

The integration of systematic molecular phenotyping into health platforms represents a paradigm shift from one-size-fits-all medicine to highly individualized diagnostic and therapeutic approaches [85]. This approach involves comprehensive measurement of molecular categories—genomics, transcriptomics, proteomics, metabolomics—to create precise patient profiles [85]. When applied to menstrual cycle research, these technologies enable unprecedented investigation into how cyclical hormonal changes influence molecular pathways and physiological responses. The global personalized medicine market, valued at $654.46 billion in 2025 and projected to reach $1,315.43 billion by 2034, reflects the significant momentum behind these approaches [86]. For researchers studying menstrual cycle associations, these platforms provide the analytical framework to move beyond observational symptom tracking to mechanistic understanding of cycle-mediated biology.

Molecular Phenotyping Technologies for Cycle Research

Core Molecular Phenotyping Approaches

Systematic molecular phenotyping encompasses multiple "-omics" technologies that provide complementary insights into physiological states [85]. Each technology targets a different level of biological organization, from genetic blueprint to metabolic output, enabling researchers to build comprehensive models of menstrual cycle influences.

Table 1: Molecular Phenotyping Technologies Relevant to Menstrual Cycle Research

Technology	Analytical Focus	Application in Cycle Research	Sample Requirements
Genomics [85]	Entire complement of genetic material	Identify genetic modifiers of cycle-associated symptoms	DNA from blood, saliva, or buccal swabs
Transcriptomics [85]	Gene expression patterns via mRNA levels	Track expression changes across cycle phases	RNA from blood, tissue biopsies, or immune cells
Proteomics [85]	Comprehensive protein expression and modifications	Quantify inflammatory mediators, receptor expression	Serum, plasma, or tissue extracts
Metabolomics [85]	Small molecule metabolites downstream of cellular processes	Monitor metabolic shifts throughout cycle	Serum, plasma, or urine
Epigenetics [85]	Reversible regulation of gene activity (e.g., methylation)	Investigate cycle-mediated epigenetic regulation	DNA from relevant tissues or blood

Integrated Personalized Health Platforms

Personalized health technologies aggregate and analyze multidimensional data to generate individualized insights. These platforms integrate data from wearable devices (tracking physiological parameters), electronic health records (providing clinical context), and molecular profiling to create dynamic models of health and disease [86]. For menstrual cycle research, these platforms enable continuous, longitudinal data collection in real-world settings, moving beyond snapshot measurements to capture dynamic processes throughout cycle phases.

Artificial intelligence (AI) and machine learning form the analytical core of these platforms, with capabilities including understanding (processing unstructured data), reasoning (recognizing patterns and relationships), learning (improving from outcomes), and empowering (delivering actionable insights) [87]. Foundation models—AI systems trained on broad multimodal data—show particular promise for healthcare applications as they can adapt to new tasks without extensive retraining [88].

Application Notes: Implementing Molecular Phenotyping in Cycle Studies

Protocol: Multimodal Data Integration for Cycle Phase Classification

Objective: Classify menstrual cycle phases using integrated wearable sensor data and molecular biomarkers.

Experimental Workflow:

• Participant Recruitment & Eligibility

  • Recruit premenopausal females aged 18-45 with regular cycles (21-35 days)
  • Exclude participants using hormonal contraception, pregnant, or breastfeeding
  • Obtain informed consent for data collection and molecular analysis

• Data Collection Schedule & Parameters

  • Daily wearable data: Skin temperature, heart rate, heart rate variability, sleep patterns collected via wrist-worn devices [11]
  • Molecular sampling: Fasting blood draws during four key phases: early follicular (cycle days 2-4), late follicular (1-2 days pre-ovulation), ovulatory (LH surge confirmed), and mid-luteal (7-9 days post-ovulation) [1]
  • Phase confirmation: Urinary luteinizing hormone (LH) tests to detect ovulation; first day of menses recorded for cycle alignment [1]

• Molecular Assay Parameters

  • Genomic analysis: GWAS array or whole exome sequencing for genetic variant identification [89]
  • Transcriptomic profiling: RNA sequencing from peripheral blood mononuclear cells (PBMCs)
  • Proteomic analysis: Multiplex immunoassays for inflammatory cytokines, reproductive hormones
  • Metabolomic profiling: LC-MS for lipid mediators, amino acids, energy metabolites

• Data Integration & Modeling

  • Feature extraction: Calculate summary statistics (mean, variance) for physiological signals across cycle phases [11]
  • Model training: Implement random forest or gradient boosting classifiers using leave-one-subject-out cross-validation [11]
  • Performance validation: Assess accuracy, precision, recall, and AUC-ROC for phase classification [11]

Data Analysis: Quantitative Menstrual Cycle Characteristics

Large-scale observational studies using mobile health applications have revealed significant variations in menstrual cycle characteristics that challenge traditional clinical assumptions [67]. Understanding this natural variability is essential for designing appropriately powered molecular phenotyping studies.

Table 2: Menstrual Cycle Characteristics from Large-Scale Observational Data (n=612,613 cycles)

Parameter	Overall Mean	By Age (25-45 years)	By Cycle Length	Clinical Implications
Cycle Length	29.3 days	Decreases by 0.18 days/year [67]	21-35 days (normal range)	Challenges 28-day assumption in study design
Follicular Phase	16.9 days (95% CI: 10-30)	Decreases by 0.19 days/year [67]	Highly variable (34-66% difference in extremes)	Primary source of cycle length variation
Luteal Phase	12.4 days (95% CI: 7-17)	No significant change with age [67]	Relatively stable (5% difference in extremes)	More consistent across populations
Cycle Variability	0.4 days higher in BMI >35	Decreases with age (20% reduction from youngest to oldest) [67]	Affects phase prediction accuracy	Impacts sampling protocol design

The Scientist's Toolkit: Essential Research Reagents & Technologies

Implementation of molecular phenotyping in menstrual cycle research requires specialized reagents and technologies designed for sensitive, precise measurement of molecular species across dynamic physiological states.

Table 3: Essential Research Reagents for Molecular Phenotyping in Cycle Studies

Category	Specific Reagents/Technologies	Application	Technical Considerations
Genomic Analysis	Whole exome sequencing kits; GWAS arrays; Targeted SNP panels	Identify genetic contributors to cycle-related disorders	Focus on genes involved in hormone metabolism, receptor function
Transcriptomic Profiling	RNA stabilization reagents; Single-cell RNAseq kits; qPCR assays	Measure gene expression changes across cycle phases	Rapid sample processing critical for RNA integrity
Proteomic Analysis	Multiplex cytokine/chemokine panels; Hormone immunoassays; Mass spectrometry reagents	Quantify protein-level responses to hormonal changes	Consider dynamic range for inflammatory vs. reproductive markers
Metabolomic Platforms	LC-MS lipidomics kits; NMR spectroscopy reagents; Targeted metabolite panels	Characterize metabolic shifts throughout cycle	Standardized collection conditions essential for reproducibility
Wearable Sensors	Wrist-based devices with temperature, HRV, EDA monitoring; Smartphone apps for symptom tracking	Continuous physiological monitoring across cycles	Validation against gold-standard measures required

Advanced Protocol: AI-Driven Phase Prediction & Molecular Correlation

Objective: Develop personalized menstrual phase prediction models and identify phase-specific molecular signatures.

Methodology:

• High-Density Physiological Monitoring

  • Collect continuous data from multi-parameter wearable devices (skin temperature, heart rate, heart rate variability, electrodermal activity) [11]
  • Implement quality control checks for signal artifacts and missing data

• Phase Definition & Labeling

  • Menses: First day of bleeding to complete cessation (self-reported) [1]
  • Follicular phase: Day after menses ends until LH surge detection [11]
  • Ovulation: Period spanning 2 days before to 3 days after positive LH test [11]
  • Luteal phase: Day after ovulation until day before next menses [11]

• Machine Learning Implementation

  • Feature engineering: Extract time-domain, frequency-domain, and nonlinear features from physiological signals [11]
  • Model selection: Compare random forest, gradient boosting, and neural network architectures
  • Validation approach: Use leave-last-cycle-out or leave-one-subject-out cross-validation [11]

• Molecular Correlation Analysis

  • Perform differential expression analysis of molecular data across predicted phases
  • Identify molecular signatures that distinguish phase transitions
  • Build multiscale models integrating physiological and molecular data

Implementation Considerations & Technical Challenges

Successful implementation of molecular phenotyping in menstrual cycle research requires addressing several methodological challenges:

Temporal Dynamics & Sampling Protocols The menstrual cycle represents a dynamic physiological system with different temporal patterns across molecular domains. Genomic markers remain stable throughout the cycle, while transcriptomic, proteomic, and metabolomic profiles demonstrate phase-specific fluctuations [85]. Research protocols must establish appropriate sampling frequencies to capture these dynamics while remaining feasible for participants. For many applications, targeted sampling during key phase transitions (follicular to ovulatory, ovulatory to luteal) provides the most informative data while minimizing participant burden [1].

Data Integration & Modeling Challenges The multidimensional data generated by molecular phenotyping platforms requires sophisticated analytical approaches. Researchers must address challenges of data heterogeneity (combining continuous wearable data with discrete molecular measurements), temporal alignment (synchronizing data streams collected at different frequencies), and missing data (addressing uneven sampling across participants and cycles) [11]. Multimodal machine learning approaches that can handle these complexities are essential for extracting meaningful biological insights.

Validation & Reproducibility Rigorous validation is particularly important in menstrual cycle research given the natural variability between cycles and individuals. Recommended approaches include within-individual replication (tracking multiple cycles from the same participant), independent cohort validation (confirming findings in separate populations), and methodological triangulation (correlating wearable-based phase predictions with hormonal measurements) [1]. These strategies enhance confidence in research findings and facilitate translation to clinical applications.

Molecular phenotyping and personalized health platforms represent transformative technologies for menstrual cycle research, enabling unprecedented resolution into the molecular and physiological changes that occur throughout cyclical hormonal fluctuations. The protocols and applications detailed in this document provide a framework for researchers to implement these approaches in studies of cycle-mediated biology, disorders such as premenstrual dysphoric disorder (PMDD), and hormone-responsive conditions. As these technologies continue to evolve—with advances in sensor miniaturization, molecular assay sensitivity, and AI-driven analytics—they promise to deepen our understanding of menstrual cycle biology and enable truly personalized approaches to managing cycle-related health concerns.

Conclusion

The integration of sophisticated data visualization techniques is paramount for advancing menstrual cycle research from descriptive studies to mechanistic insights and clinical applications. By adhering to standardized definitions, leveraging temporal and comparative visuals, and proactively addressing methodological pitfalls, researchers can unlock a more precise understanding of cycle-associated phenomena. The validation of machine learning models and wearable-derived biomarkers against established endocrinological benchmarks represents a promising frontier, offering the potential for personalized health monitoring and large-scale epidemiological discovery. However, this progress must be guided by rigorous ethical standards to ensure algorithms empower rather than discriminate. Ultimately, mastering these visualization and analytical techniques will accelerate diagnosis, inform drug development, and finally address the profound unmet needs in women's health.

References

• 1. How to study the menstrual cycle - PubMed Central - NIH [https://pmc.ncbi.nlm.nih.gov/articles/PMC8363181/]
• 2. Cycleplot Techniques for Clarity in Data Visualization [https://insightsoftware.com/encyclopedia/cycleplot/]
• 3. Establishing a Gold Standard for Quantitative Menstrual ... [https://www.mdpi.com/1648-9144/59/9/1513]
• 4. The Power of Data Visualization in Life Cycle Assessment [https://earthshiftglobal.com/blog/from-numbers-to-insights-the-power-of-data-visualization-in-life-cycle-assessment]
• 5. Presenting Quantitative Data Graphically [https://courses.lumenlearning.com/waymakermath4libarts/chapter/presenting-quantitative-data-graphically/]
• 6. Presentation of Quantitative Data [https://ihatepsm.com/blog/presentation-quantitative-data]
• 7. Understanding WCAG 2 Contrast and Color Requirements [https://webaim.org/articles/contrast/]
• 8. Color Contrast | Web Accessibility Checklist [https://dequeuniversity.com/checklists/web/color-contrast]
• 9. Data Visualizations for Machine Learning [https://cycle.io/learn/data-visualization-for-machine-learning]
• 10. The Normal Menstrual Cycle and the Control of Ovulation - NCBI [https://www.ncbi.nlm.nih.gov/books/NBK279054/]
• 11. Machine learning-based menstrual phase identification ... [https://www.nature.com/articles/s44294-025-00078-8]
• 12. Hormonal milieu influences whole-brain structural ... [https://www.nature.com/articles/s41593-025-02066-2]
• 13. Machine learning model for menstrual cycle phase ... [https://www.sciencedirect.com/science/article/pii/S0010482525000551]
• 14. SensorLM: Learning the language of wearable sensors [https://research.google/blog/sensorlm-learning-the-language-of-wearable-sensors/]
• 15. Smart sensors and smarter health: How AI and wearables ... [https://healthsciences.arizona.edu/news/stories/smart-sensors-and-smarter-health-how-ai-and-wearables-are-reimagining-preventive-health-care]
• 16. Continuous Hormone Monitoring Market Growth 2025-2035 [https://www.futuremarketinsights.com/reports/continuous-hormone-monitoring-market]
• 17. Data Visualization with Period-Over-Period Charts [https://www.domo.com/learn/charts/period-over-period-charts]
• 18. Your Data Visualization Color Guide: 7 Best Practices | Sigma [https://www.sigmacomputing.com/blog/7-best-practices-for-using-color-in-data-visualizations]
• 19. The 5 Best Period Tracker Apps in 2025 - Reviewed & Rated [https://bearable.app/the-best-period-tracker-apps-of-2025/]
• 20. What to consider when choosing colors for data visualization [https://academy.datawrapper.de/article/140-what-to-consider-when-choosing-colors-for-data-visualization]
• 21. Chromosome Analysis and Sorting Using Conventional ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10947383/]
• 22. Exploratory Data Analysis using Data Visualization ... [https://dev.to/daveseme/exploratory-data-analysis-using-data-visualization-techniques-4n48]
• 23. What is Exploratory Data Analysis? [https://www.geeksforgeeks.org/data-analysis/what-is-exploratory-data-analysis/]
• 24. Implicit motor imagery performance and cortical activity ... [https://www.nature.com/articles/s41598-022-25766-2]
• 25. DataViz protocols - Joachim Goedhart [https://joachimgoedhart.github.io/DataViz-protocols/]
• 26. How to choose colors for data visualizations [https://www.atlassian.com/data/charts/how-to-choose-colors-data-visualization]
• 27. Survey Analysis of Quantitative and Qualitative Menstrual ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10534579/]
• 28. How to study the menstrual cycle: Practical tools and ... [https://www.sciencedirect.com/science/article/abs/pii/S0306453020303188]
• 29. Menstrual cycle effects on cognitive performance: A meta ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11913300/]
• 30. Presenting data in tables and charts - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC4008059/]
• 31. Between-Subjects vs. Within-Subjects Study Design [https://www.nngroup.com/articles/between-within-subjects/]
• 32. Determining Menstrual Cycle Phase: An Empirical Examination of Methodologies and Recommendations for Improvement in Behavioral and Brain Sciences - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10714354/]
• 33. Menstrual Cycle Phase Influences Cognitive Performance in Women and Modulates Sex Differences: A Combined Longitudinal and Cross-Sectional Study - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC12384028/]
• 34. Menstrual Cycle Phase Influences Cognitive Performance ... [https://www.mdpi.com/2079-7737/14/8/1060]
• 35. Mastering The Art of Data Visualization Color Palettes [https://www.datylon.com/blog/a-guide-to-data-visualization-color-palette]
• 36. Ten simple rules to colorize biological data visualization - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7561171/]
• 37. Visual communication of public health data: a scoping review [https://pmc.ncbi.nlm.nih.gov/articles/PMC12060258/]
• 38. Color Contrast Accessibility: Complete WCAG 2025 Guide ... [https://www.allaccessible.org/blog/color-contrast-accessibility-wcag-guide-2025]
• 39. Understanding Success Criterion 1.4.3: Contrast (Minimum) [https://www.w3.org/WAI/WCAG21/Understanding/contrast-minimum.html]
• 40. Steps Toward Health Data Standards for Wearables [https://spectrum.ieee.org/wearable-health-data-standards]
• 41. Establishing Standards for Data and Metadata from Wearable ... [https://www.nimh.nih.gov/funding/grant-writing-and-application-process/concept-clearances/2024/establishing-standards-for-data-and-metadata-from-wearable-devices]
• 42. Data Analysis and Visualization - Research Data Management [https://guides.library.txstate.edu/research-data/analysis-visualization]
• 43. Quantitative Data Analysis. A Complete Guide [2025] [https://www.6sigma.us/six-sigma-in-focus/quantitative-data-analysis/]
• 44. Wearable Technology Guidance [https://www.uwmedicine.org/about/policies-and-notices/wearable-technology-guidance]
• 45. Determination of luteal phase length by quantitative basal ... [https://pubmed.ncbi.nlm.nih.gov/2364587/]
• 46. Methods for Tracking Your Fertility and Ovulation [https://walnuthillobgyn.com/blog/methods-for-tracking-your-fertility-and-ovulation/]
• 47. Current ovulation and luteal phase tracking methods ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11837971/]
• 48. Variation in Auditory and Visual Reaction Time across the ... [https://www.jccpractice.com/article/variation-in-auditory-and-visual-reaction-time-across-the-menstrual-cycle-a-quantitative-analysis-1038/]
• 49. Prospective 1-year assessment of within-woman variability of follicular ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11532606/]
• 50. Complexities in salivary and urinary methodology for ... [https://gremjournal.com/journal/01-2025/complexities-in-salivary-and-urinary-methodology-for-ovulation-and-menstrual-cycle-hormone-detection-a-scoping-review/]
• 51. Challenges and future directions in menstrual cycle research [https://pmc.ncbi.nlm.nih.gov/articles/PMC7192772/]
• 52. Why We Must Stop Assuming and Estimating Menstrual ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12152053/]
• 53. Tackling biases in clinical trials to ensure diverse ... [https://www.nature.com/articles/s41467-024-45718-w]
• 54. Visualizing associations among two or more quantitative ... [https://clauswilke.com/dataviz/visualizing-associations.html]
• 55. 17 Important Data Visualization Techniques - HBS Online [https://online.hbs.edu/blog/post/data-visualization-techniques]
• 56. 5.6 Data Visualization [https://web.stevenson.edu/mbranson/m4tp/version1/greenhouse-gas-math-topic-data-visualization.html]
• 57. Missing Data in R? Complete 2025 Guide to Imputation ... [https://medium.com/@diptim_99684/missing-data-in-r-complete-2025-guide-to-imputation-techniques-727173f24555]
• 58. Handling Missing Data in R: A Comprehensive Guide [https://www.r-bloggers.com/2025/08/handling-missing-data-in-r-a-comprehensive-guide/]
• 59. The Art of Handling Outlier [https://medium.com/@post.gourang/the-art-of-handling-outlier-153215d49460]
• 60. Detecting and Treating Outliers | Treating the odd one out! [https://www.analyticsvidhya.com/blog/2021/05/detecting-and-treating-outliers-treating-the-odd-one-out/]
• 61. Top 5 Statistical Techniques to Detect and Handle Outliers ... [https://www.statology.org/top-5-statistical-techniques-detect-handle-outliers-data/]
• 62. Chartjunk: How to Avoid Confusing Elements in Your Figures [https://www.enago.com/academy/chartjunk-how-to-avoid-confusing-elements-in-your-figures/]
• 63. Avoid chartjunk in presentations: Three lessons from Tufte [https://www.brightcarbon.com/blog/avoid-chartjunk-in-presentations-3-lessons-from-tufte/]
• 64. 10 Essential Data Visualization Best Practices for 2025 [https://www.timetackle.com/data-visualization-best-practices/]
• 65. Simplifying Complex Data Visualizations [https://www.storytellingwithcharts.com/blog/cluttered-to-concise-simplifying-complex-data-visualizations/]
• 66. Data Visualization Tips and Best Practices [https://www.tableau.com/visualization/data-visualization-best-practices]
• 67. Real-world menstrual cycle characteristics of more than ... [https://www.nature.com/articles/s41746-019-0152-7]
• 68. The Art of Effective Visualization of Multi-dimensional Data [https://medium.com/data-science/the-art-of-effective-visualization-of-multi-dimensional-data-6c7202990c57]
• 69. Validating At-Home Urinary Hormone Measurements in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12040536/]
• 70. Serum LH levels before progesterone administration ... [https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-025-01743-x]
• 71. Comparison of Day-Specific Serum LH, Estradiol, and ... [https://www.mdpi.com/1648-9144/60/8/1207]
• 72. Comparison of two ovulation tests to predict timing of the ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12012743/]
• 73. Menstrual Cycle Management and Period Tracker App Use ... [https://www.jmir.org/2024/1/e53146/]
• 74. Modern fertility awareness methods: wrist wearables ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC6265623/]
• 75. Successful Implementation of Menstrual Cycle Biomarkers in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9956032/]
• 76. Traditional and Digital Biomarkers: Two Worlds Apart? - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7015353/]
• 77. Machine learning model for menstrual cycle phase ... [https://pubmed.ncbi.nlm.nih.gov/39889448/]
• 78. Color palettes and accessibility features for data visualization [https://medium.com/carbondesign/color-palettes-and-accessibility-features-for-data-visualization-7869f4874fca]
• 79. 8.3 Ethics in Visualization and Reporting [https://openstax.org/books/principles-data-science/pages/8-3-ethics-in-visualization-and-reporting]
• 80. Data Ethics: Frameworks, Principles & Challenges (2025) [https://atlan.com/data-ethics-101/]
• 81. Ethical Data Visualisation: Avoiding Bias and ... [https://medium.com/@harry.trivedi/ethical-data-visualization-avoiding-bias-and-misinformation-in-your-charts-and-graphs-02b1f506f68f]
• 82. Figures and Charts - UNC Writing Center [https://writingcenter.unc.edu/tips-and-tools/figures-and-charts/]
• 83. 11 Summarising quantitative data | Scientific Research and ... [https://bookdown.org/pkaldunn/SRM-Textbook/SummariseQuantData.html]
• 84. Text has enhanced contrast | ACT Rule | WAI [https://www.w3.org/WAI/standards-guidelines/act/rules/09o5cg/]
• 85. A Path Towards Precision Emergency Medicine? [https://pmc.ncbi.nlm.nih.gov/articles/PMC5055430/]
• 86. The Future of Personalized Healthcare Technology [https://www.wavetec.com/blog/future-of-personalized-healthcare-technology/]
• 87. Precision Medicine, AI, and the Future of Personalized Health ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7877825/]
• 88. 7 Key Trends Shaping the Future of Healthcare [https://research.gehealthcare.com/across-the-enterprise/7-key-trends-shapxxx-the-future-of-healthcare-jb31184xx/]
• 89. Next-generation phenotyping integrated in a national ... [https://www.nature.com/articles/s41588-024-01836-1]